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Background-—The impact of different types of extracranial bleeding events on health-related quality of life and health-state utility
among patients with atrial ﬁbrillation is not well understood.
Methods and Results-—The ENGAGE AF-TIMI 48 (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation–
Thrombolysis in Myocardial Infarction 48) Trial compared edoxaban with warfarin with respect to the prevention of stroke or
systemic embolism in atrial ﬁbrillation. Data from the EuroQol-5D (EQ-5D-3L) questionnaire, prospectively collected at 3-month
intervals for up to 48 months, were used to estimate the impact of different categories of bleeding events on health-state utility
over 12 months following the event. Longitudinal mixed-effect models revealed that major gastrointestinal bleeds and major
nongastrointestinal bleeds were associated with signiﬁcant immediate decreases in utility scores (0.029 [0.044 to 0.014;
P<0.001] and 0.029 [0.046 to 0.012; P=0.001], respectively). These effects decreased in magnitude over time, and were no
longer signiﬁcant for major nongastrointestinal bleeds at 9 months, but remained borderline signiﬁcant for major gastrointestinal
bleeds at 12 months. Clinically relevant nonmajor and minor bleeds were associated with smaller but measurable immediate
impacts on utility (0.010 [0.016 to 0.005] and 0.016 [0.024 to 0.008]; P<0.001 for both), which remained relatively
constant and statistically signiﬁcant over the 12 months following the bleeding event.
Conclusions-—All categories of bleeding events were associated with negative impacts on health-state utility in patients with atrial
ﬁbrillation. Major bleeds were associated with relatively large immediate decreases in utility scores that gradually diminished over
12 months; clinically relevant nonmajor and minor bleeds were associated with smaller immediate decreases in utility that
persisted over 12 months.
Clinical Trial Registration-—URL: https://www.clinicaltrials.gov/. Unique identiﬁer: NCT00781391. ( J Am Heart Assoc. 2017;6:
e006703. DOI: 10.1161/JAHA.117.006703.)
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C ontemporary management of atrial ﬁbrillation (AF)imposes many challenges. Anticoagulation in patients
with AF involves a careful balance between maximizing the
beneﬁt with respect to the prevention of stroke while
minimizing the bleeding risk. Several novel oral anticoagulants
have been approved and released on the market as
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alternatives to warfarin in recent years; in a meta-analysis, the
novel oral anticoagulants signiﬁcantly reduced stroke/
systemic embolic event (SEE), mortality and intracranial
hemorrhage (ICH), while gastrointestinal bleeding was
increased.1 Relative to warfarin, the novel oral anticoagulants
have the additional beneﬁt of greater ease of use.
Prior studies have revealed that patients with AF have
impaired quality of life (QOL) and that QOL scores are
inﬂuenced by age, sex, and baseline medical conditions.2–6
Few studies have examined the impact of adverse events such
as bleeding on QOL in patients with AF7 and little is known
about the impact of different types of bleeding events on QOL,
and whether and how that impact changes over time. Insight
into the impact of different categories of nonfatal bleeding
events on health-state utility in patients with AF receiving oral
anticoagulant therapy may provide a framework to improve
understanding of the net clinical beneﬁt and cost-effective-
ness of novel oral anticoagulant therapies relative to warfarin.
The ENGAGE AF-TIMI 48 (Effective Anticoagulation with
Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in
Myocardial Infarction 48) Trial was a 3-arm, randomized,
double-blind, double-dummy trial comparing 2 once-daily dose
regimens of edoxaban (higher dose [60 mg] and lower dose
[30 mg]) to warfarin with respect to the prevention of stroke
or systemic embolism in patients with AF. We used data from
ENGAGE AF-TIMI 48 to examine the impact of different
categories of extracranial bleeding events on health-state
utility scores for patients with AF, and how the impact of




The design, methods, and clinical results of the ENGAGE AF-
TIMI 48 trial have been described previously.8,9 Brieﬂy,
patients from 1393 centers in 46 countries were enrolled
between November 2008 and November 2010. Eligible
patients were randomly assigned in a 1:1:1 ratio to receive
warfarin, dose-adjusted to achieve an international normalized
ratio of 2.0 to 3.0 or to receive higher-dose 60 mg, or lower-
dose 30-mg edoxaban regimens; the dose of edoxaban in
each arm was reduced by 50% in patients with anticipated
increased exposure based on creatinine clearance, body
weight, and concomitant permeability glycoprotein inhibitor
use. Patients with a high risk of bleeding such as history of
prior ICH, major bleeding or peptic ulcer disease within
1 year, hemorrhagic disorders, thrombocytopenia, need for
dual antiplatelet therapy, severe renal failure, moderate or
severe hepatic insufﬁciency, active infective endocarditis,
uncontrolled hypertension (blood pressure >170/
100 mm Hg), or recent severe trauma, major surgery, or
deep organ biopsy within the previous 10 days, were all
excluded. The study was approved by the institutional review
board at each site, and all patients provided written informed
consent before participation.
Quality of Life Assessments
Quality of life was assessed using the self-administered
EuroQol 5 Dimension questionnaire, which was completed at
baseline and at 3-month intervals for up to 4 years (median
2.8 years) by a subsample of 80% of patients from the
overall trial population. The EuroQol 5 Dimension question-
naire is a generic health status measure consisting of 5
domains (mobility, self-care, usual activities, pain/discomfort,
and anxiety/depression) that can be converted to utilities
using an algorithm developed for the US population.10 Utilities
are preference-based health status measures and range from
0 to 1, with 1 representing perfect health and 0 corresponding
to the worst imaginable health state.11 The EuroQol 5
Dimension questionnaire has been extensively validated and
frequently used to assess health-state utility and health-
related QOL in health economic studies for patients with
cardiovascular disease.12 For the purposes of this study, only
patients who had baseline and at least 1 follow-up QOL
assessment were included in the study population.
Clinical Perspective
What Is New?
• The impact of different types of extracranial bleeding events
on health-state utility among patients with atrial ﬁbrillation
was examined using data from the ENGAGE AF-TIMI 48
(Effective Anticoagulation With Factor Xa Next Generation in
Atrial Fibrillation–Thrombolysis in Myocardial Infarction 48)
trial.
• Compared with clinically relevant nonmajor and minor
bleeds, major gastrointestinal and nongastrointestinal
bleeds were associated with larger immediate decrements
in utility scores that decreased gradually over the year
following the bleeding event and were no longer statistically
signiﬁcant at 12 months.
• In contrast, clinically relevant and minor bleeding events
were associated with smaller but statistically signiﬁcant
initial decreases in utility that persisted for 12 months.
What Are the Clinical Implications?
• These ﬁndings have potential use in future studies of the net
clinical beneﬁt and cost-effectiveness of alternative strate-
gies for stroke prevention in patients with atrial ﬁbrillation.
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Bleeding End Points
The primary safety end point in ENGAGE AF–TIMI 48 was
adjudicated major bleeding. Spontaneous bleeding events
requiring medical attention were adjudicated by an indepen-
dent and blinded clinical events committee, according to
prespeciﬁed criteria as deﬁned by the International Society on
Thrombosis and Haemostasis.13 The speciﬁc event categories
included major gastrointestinal bleeding, major nongastroin-
testinal bleeding, and clinically relevant nonmajor (CRNM)
bleeding. Major bleeds include symptomatic bleeding in a
critical area or organ, such as intraspinal, intraocular,
retroperitoneal, intraarticular, or pericardial, or intramuscular
with compartment syndrome and/or bleeding causing a
decrease in hemoglobin level of 2 g/dL (1.24 mmol/L) or
more, or leading to transfusion of 2 or more units of whole
blood or red blood cells. CRNM bleeds are acute or subacute
clinically overt bleeds that do not meet the criteria for major
bleed but prompt a clinical response, in that they lead to at
least 1 of the following: a hospital admission for bleeding; a
physician-guided medical or surgical treatment for bleeding;
or a change in antithrombotic therapy (including interruption
or discontinuation of study drug). Bleeding events that did not
require medical attention were classiﬁed as minor bleeding,
without clinical events committee adjudication.
Statistical Analysis
Baseline clinical and demographic characteristics and QOL
scores were compared between patients included versus
excluded from this QOL study, and within the QOL study
between those with versus without bleeding events, using 2-
sample Student t tests for continuous variables and v2 or
Fisher exact tests for categorical variables. Standardized
differences, assuming a threshold of 10% for a clinically
meaningful difference,14 were calculated for the comparison
of baseline characteristics in the study sample versus those
patients excluded from the analysis, in order to evaluate the
importance of statistically signiﬁcant differences given the
large sample sizes in both groups.15 Longitudinal mixed effect
models were used to examine the impact of different
categories of bleeding events on QOL scores by modeling
bleeding events as time-varying covariates.16 These models
incorporate all available health status data from all follow-up
time points, and accommodate missing data under the
assumption of missing at random. Variables included in the
models were baseline QOL score, bleeding status, and time
relative to the bleeding event. Linear, quadratic, and cubic
effects of follow-up time were considered, as well as all
corresponding interactions between follow-up time and
bleeding status. The interactions between bleeding status
and time elapsed since the bleeding events were added to the
models to assess any changes in the impact of bleeding
events over time. In addition, age, sex, and all other baseline
clinical characteristics listed in Table were included in the
model development. The models were optimized using a
backward selection process and only variables with P<0.1
were retained.
To avoid potential confounding of other vascular events on
the estimated impact of bleeding events on QOL outcomes,
patients who experienced any stroke, transient ischemic
attack, myocardial infarction, or systemic embolic event were
censored on the date of the ﬁrst thrombotic event. In addition,
patients who experienced multiple bleeding events of either
the same or different types were censored on the date of the
second bleeding event. Any QOL measures on or after the
date of censoring were thereby excluded from the analysis.
All analyses were performed using SAS for Windows
version 9.4 (SAS Institute, Cary, NC), and a 2-tailed P<0.05
was considered statistically signiﬁcant for all comparisons.
Results
Patient Population and Baseline QOL
A total of 21 105 patients were enrolled in the ENGAGE AF–
TIMI 48 trial, of whom 10 706 had baseline and at least 1
follow-up EQ-5D collected. Most of the standardized differ-
ences between the patients included versus excluded from
the QOL study were <10%; only the standardized differences
in creatinine clearance, CHADS2 score, dyslipidemia, and
hypertension were slightly higher than 10% (Table S1). These
results suggest no substantial difference between the 2
cohorts. Patients excluded speciﬁcally because of having no
follow-up QOL assessments (n=236) had lower mean baseline
EQ-5D utility scores than those included in the analysis (0.836
versus 0.808, P=0.004); because the analysis adjusts for
baseline score, this is unlikely to impact our ﬁndings. There
were 2492 patients in the QOL study population for whom a
spontaneous nonintracranial bleed was reported as a ﬁrst
event; 207 of these were major gastrointestinal bleeds, and
152, 1419, and 714 were major nongastrointestinal, CRNM,
and minor bleeds, respectively. One hundred thirty-seven ICH
were observed in the study population, though only 23 of
these ICH events were the ﬁrst event for the patient;
therefore, ICH bleed was not analyzed because of small
sample size.
For each bleeding category, patients with versus without a
bleeding event were older and more likely to have a history of
non-ICH bleeding history and prior coronary artery bypass
graft at baseline (Table). Baseline EQ-5D utility scores did not
differ for patients with versus without a bleeding event.
Completeness of QOL data collection was high (>90%)
DOI: 10.1161/JAHA.117.006703 Journal of the American Heart Association 3
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throughout the entire study period among the 10 706
patients who were included in this analysis (Table S2),
although it tended to be slightly lower for patients with versus
without major gastrointestinal bleeding events beginning at
the 6-month follow-up and thereafter.
Impact of Bleeding on Quality of Life
After adjusting for baseline score and clinical and demo-
graphic characteristics, results from the longitudinal mixed
effect models revealed that all categories of bleeding events
were associated with a signiﬁcant immediate reduction in EQ-
5D utility (Figure). Major gastrointestinal and nongastroin-
testinal bleeding events had similar immediate impacts on
utility (0.029 [95% CI: 0.044–0.014; P<0.001] and
0.029 [95% CI: 0.046 to 0.012; P=0.001], respectively).
CRNM and minor bleeding events were associated with
smaller but measurable immediate impacts on utility (0.010
[95% CI: 0.016 to 0.005; P<0.001] and 0.016 [95% CI:
0.024 to 0.008; P<0.001], respectively).
Figure demonstrates the estimated impact of bleeding over
time, for each of the categories of bleeding events. For major
gastrointestinal and nongastrointestinal bleeds, the impact on
utility scores consistently decreased in magnitude over time;
while the impact of major nongastrointestinal bleeds was no
longer statistically signiﬁcant at 9 months, the impact of
major gastrointestinal bleeds on utility scores remained
borderline signiﬁcantly (0.011 points, P=0.058) at
12 months. The impacts of CRNM and minor bleeding events
on utility were smaller but persisted throughout 12 months
with no clear temporal trend.
Discussion
Bleeding is the most common complication associated with
anticoagulation management in patients with AF. The frequent
(3-month intervals) assessment of QOL with the EQ-5D
questionnaire in the ENGAGE AF—TIMI 48 trial allowed us to
estimate the impact of extracranial bleeding events on health-
state utility over the course of 12 months following the event.
All categories of bleeding events were associated with
signiﬁcant immediate decreases in EQ-5D utility. Compared
with CRNM and minor bleeds, major gastrointestinal and
nongastrointestinal bleeds were associated with larger imme-
diate decrements in utility scores that decreased gradually
over the year following the bleeding event and were no longer
statistically signiﬁcant at 12 months. In contrast, CRNM and
minor bleeding events were associated with smaller but
statistically signiﬁcant initial decreases in utility that persisted
for 12 months. The persistence of this decrease is unex-
pected, and may be because of unmeasured confounding in
the population that experiences minor bleeds. The larger
relative magnitude of the impact of minor versus CRNM
bleeds on utility may be related to the fact that by deﬁnition,
CRNM bleeding events require some degree of medical
intervention, whereas minor bleeding events do not.
To put the estimated immediate disutilities associated with
major, CRNM, and minor bleeding events of 0.020, 0.010,
and0.016 from our study in context, a study of complication-
speciﬁc changes in utility based on longitudinal data from
patients with type 2 diabetes mellitus reported decreases in
EQ-5D-derived utility scores ranging from 0.026, 0.045,
and0.049 for myocardial infarction, congestive heart failure,
and renal failure, to 0.083, 0.099, and 0.122 for
Figure. Estimated impact of bleeding events on EQ-5D utility. EQ-5D indicates EuroQol 5 Dimension questionnaire; GI, gastrointestinal; CRNM,
clinically relevant nonmajor.
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blindness, stroke, and amputation, respectively.17 The esti-
mated immediate decreases in EQ-5D utility scores with
bleeding events from our study are comparable to estimates
reported in other studies involving other patient populations.
For example, using data from the TRANSLATE-ACS (Treatment
With Adenosine Diphosphate Receptor Inhibitors: Longitudinal
Assessment of Treatment Patterns and Events After Acute
Coronary Syndrome) study, Amin et al18 reported that among
patients who underwent percutaneous coronary intervention
for acute myocardial infarction, bleeding events, classiﬁed
according to the Bleeding Academic Research Consortium
(BARC) criteria, that occurred between discharge and
6 months postacute myocardial infarction were associated
with a mean reduction in utility scores of 0.033 points at
6 months. More severe bleeding events (BARC types 3 or 4)
were associated with larger decrements in utility (0.045
points), whereas even minor bleeds (BARC type 1) were
associated with smaller but still detectable decreases in utility.
A similar ﬁnding was observed for patients with acute
myocardial infarction with respect to nuisance bleeding, which
was found to be independently associated with worse QOL at
1 month.19 Our study is unique, however, given its examina-
tion of the trajectory of QOL outcomes over 12 months
following the bleeding event. The lack of statistical signiﬁcance
with respect to the estimated utility decrements at 9 months
for major nongastrointestinal bleeds and at 12 months for
major gastrointestinal and major nongastrointestinal bleeds
may be because of the relatively small number of events (207
and 152 major gastrointestinal and nongastrointestinal
bleeds, respectively, as compared with 1419 and 714 CRNM
and minor bleeds, respectively) or survivor bias resulting from
a higher death rate for patients with more severe bleeds.
These estimates of the pattern of utility changes over time
for bleeding events in patients with AF have implications for
the estimation of quality-adjusted life years in cost-effective-
ness studies. In recent years, studies of the cost-effectiveness
of anticoagulation or other approaches to stroke prevention in
patients with AF have generally applied utility estimates from
a limited number of available sources including the Beaver
Dam Health Outcomes Study and the national catalog of
preference-based scores for chronic conditions in the United
States.20–26 However, both of these sources are based on
data obtained from general community populations, and
therefore the utility/disutility estimates may not pertain to
patients with AF. Moreover, in cost-effectiveness analyses,
the impact of bleeding events is often assumed to be
transient.23,24,27 For example, published cost-effectiveness
analyses comparing apixaban and edoxaban versus warfarin
assumed disutilities of 0.1511 lasting 2 weeks for major
extracranial hemorrhage, 0.0582 lasting 2 days for CRNM
bleeds, and 0.013 lasting 2 days for minor bleeds.28,29 Even
with the assumption of no impact on utility beyond 1 year for
all categories of extracranial bleeds, results from the current
study suggest that disutilities for all categories of bleeds from
the patient’s perspective may be greater in magnitude than
previously assumed. This could have an impact for the
evaluation of net clinical beneﬁt, comparative effectiveness,
and cost-effectiveness evaluation of alternative anticoagula-
tion strategies, for which chronic utility and temporary
disutility weights are or might be used to combine different
clinical events into a common metric.
Results from an analysis of data from the RE-LY trial
examining the impact of therapy with dabigatran versus
warfarin on health-state utility in patients with no major
clinical events found no evidence to suggest that the relative
complexity and inconveniences of management with warfarin
versus dabigatran yielded any measurable decrement in
health-state utility.30 The double-blind double-dummy design
of the ENGAGE AF-TIMI 48 trial precluded us from exploring
the impact of international normalized ratio monitoring and
dose adjustment on QOL in our analysis.
Study Limitations
This study should be considered in light of several important
limitations. The ENGAGE AF-TIMI 48 trial enrolled subjects with
AF at medium or high risk of thromboembolic events, and
excluded subjects with AF caused by a reversible disorder,
severe renal dysfunction, a high risk of bleeding, and moderate
or severe mitral stenosis. Our results may not apply to patients
outside of the select enrolled trial population. The EuroQol 5
Dimension questionnaire is a simple, generic health status
questionnaire, for which each of the 5 component domains is
measured on a 3-level scale (indicating no problem, some or
moderate problem, and extreme problem); as a result it may
have limited ability to delineate minor but important clinical
differences in health status. Despite adjustment for potential
confounders in all models, there remains the possibility of
unmeasured confounding. The exclusion of patients with no or
limited QOL information might introduce the possibility of
selection bias. Since we observed slightly more missing data in
patients with a major gastrointestinal bleed, it is possible that
the missing data could affect our results if the assumption of
missing at random does not hold, though this seems unlikely
given the high rate of QOL data collection across all bleeding
categories and follow-up time points. This study considered
only the ﬁrst bleeding event within a patient; thus the results
may not accurately relate to the impact of a second bleeding
event of either the same or different type on health-state utility.
Conclusions
In summary, in this large-scale prospective study of patients
with AF, we found that all categories of bleeding events were
DOI: 10.1161/JAHA.117.006703 Journal of the American Heart Association 6
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associated with measurable immediate decreases in health-
state utility. Major gastrointestinal and nongastrointestinal
bleeds had relatively large immediate decrements, which
decreased in magnitude over time and were no longer
statistically signiﬁcant at 12 months. CRNM and minor bleed-
ing events were associated with smaller initial decrements in
utility that remained statistically signiﬁcant and relatively
consistent in magnitude through 12 months after the bleeding
event. Collectively, these ﬁndings have potential use in future
studies of the net clinical beneﬁt and cost-effectiveness of
alternative strategies for stroke prevention in patients with AF.
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Age, years, (mean ± SD) 70.6 ± 9.5 70.6 ± 9.3 0.8 
Male 61.4 62.4 2.0 
Previous use of vitamin K antagonist 59.1 58.8 0.5 
[Diabetes mellitus 36.7 35.5 2.4 
Dyslipidemia 55.1 49.6 11.1 
Hypertension 94.9 92.3 10.8 
Prior MI 11.6 11.5 0.3 
Prior Stroke 18.3 19.0 1.9 
Prior transient ischemic attack 12.4 10.9 4.7 
Prior PAD 4.3 3.7 3.2 
Congestive heart failure 59.5 55.4 8.2 
Prior CAD 34.1 32.5 3.4 
Prior CABG 8.0 5.8 8.6 
History of ICH bleed 0.1 0.2 1.6 
History of non-ICH bleed 9.9 9.8 0.2 
History of gastrointestinal bleed 3.2 2.8 8.1 
Creatinine clearance in mg/dL, (mean ± SD) 78.6 ± 32.4 74.9 ± 30.4 11.8 
CHADS2 score (0-6) , (mean ± SD) 2.9 ± 1.0 2.8 ± 0.9 10.2 
*All results are % of patients unless otherwise specified. 
GI indicates gastrointestinal; CRNM, clinically relevant non-major, SD, standard deviation; PAD, peripheral arterial disease; CAD, coronary artery 
disease; CABG, coronary artery bypass graft; ICH intracranial hemorrhage, CHADS2, scoring system for the long-term risk of stroke in atrial 
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Table S2. Quality of life compliance by bleeding status 
Time 
(month) 





















3  100.0 100.0 1.000 100.0 100.0 1.000 100.0 100.0 1.000 100.0 100.0 1.000 
6  86.5 93.9 < 0.001 93.4 93.8 0.811 94.3 93.4 0.192 95.4 93.7 0.069 
9  86.8 93.4 < 0.001 91.3 93.4 0.311 94.7 93.0 0.020 93.9 93.3 0.481 
12 89.7 93.8 0.015 93.2 93.8 0.748 93.8 93.6 0.743 94.5 93.7 0.405 
15  90.6 93.8 0.059 95.2 93.8 0.498 94.8 93.5 0.071 93.3 93.8 0.607 
18  90.9 94.2 0.051 95.1 94.2 0.634 93.7 94.1 0.559 93.7 94.2 0.608 
21 90.8 94.1 0.054 91.5 94.1 0.190 94.2 94.0 0.713 93.9 94.0 0.941 
24 89.7 94.4 0.005 90.8 94.4 0.065 94.7 94.1 0.381 93.3 94.3 0.278 
27  92.6 94.8 0.195 95.0 94.8 0.910 93.9 94.8 0.188 94.3 94.7 0.622 
30  89.7 94.6 0.008 94.7 94.6 0.941 94.4 94.5 0.884 94.7 94.5 0.897 
33  87.3 95.4 < 0.001 95.2 95.3 0.797 94.7 95.4 0.436 95.5 95.3 0.838 
36  90.5 96.0 0.030 95.6 96.0 0.700 94.7 96.1 0.163 96.7 95.9 0.540 
39  85.7 95.5 0.022 100.0 95.3 1.000 94.3 95.7 0.345 96.6 95.2 0.453 
42 88.2 93.4 0.321 100.0 93.5 1.000 93.8 93.6 0.937 93.1 93.7 0.776 
45  100.0 94.3 1.000 100.0 94.5 1.000 93.9 94.0 1.000 95.0 94.7 1.000 
48  100.0 84.6 1.000  85.7 NA 100.0 80.0 0.523 100.0 84.6 1.000 
* the sample sizes for the “no event” categories differ according to the category of bleed due to  censoring at the time of events. All results are % of patients. 
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2Appendix 
The members of the Operations, Executive, Steering, Data Monitoring, Clinical Events 
Committees, countries, participating centers, Principal Investigators, and Primary Study 
Coordinators of the ENGAGE AF-TIMI 48 trial were as follows:  
Operations Committee: TIMI Study Group, Brigham and Women’s Hospital, Boston, MA –  
E. Braunwald (Study Chair), E.M. Antman (Principal Investigator), R.P. Giugliano (Co-Principal
Investigator), C.T. Ruff (Investigator), S.E. Morin (Director), E.B. Hoffman (Lead
Biostatistician), S.A. Murphy (Biostatistician), N. Deenadayalu (Biostatistician), L. Grip (Project
Director); Sponsor – Daiichi Sankyo Pharma Development, Edison, NJ – M. Mercuri (Vice
President, Clinical Development), H. Lanz (Executive Director, Clinical Development), I. Patel
(Executive Director, Clinical Development), V. Curt (Senior Director, Clinical Development),
A. Duggal (Senior Director, Clinical Development), J. Hanyok (Senior Director, Clinical
Development), J. Davé (Associate Director, Clinical Development), D. Morgan (Executive
Director, Regulatory Affairs), Y. Choi (Senior Director, Clinical Safety), M. Shi (Senior
Director, Biostatistics), J. Jin (Senior Biostatistician), J. Xie (Biostatistician); W. Crerand (Senior
Director, Data Management); J. Kappelhof (Senior Director, Project Management), W. Maxwell
(Associate Director, Project Management); Contract Research Organization – Quintiles,
Research Triangle Park, NC – M. Skinner (Global Operations Head), S. Patel (Project Director)
J. Betcher (Biostatician), G.  Selicato (Biostatician), C. Otto Jr. (Project Manager), C. Reissner
(Clinical Director), K. Smith (Project Manager), J. Ostroske (Project Manager), A. Ron (Project
Manager).
Executive Committee: TIMI Study Group, Brigham and Women's Hospital, Boston, MA – 
E. Braunwald, E.M. Antman, R. P. Giugliano; Daiichi Sankyo – M. Mercuri; Canada –
S. Connolly; United Kingdom – J. Camm; United States – M. Ezekowitz, J. Halperin, A. Waldo.
Steering Committee: Argentina – E. Paolasso (deceased); Australia – P. Aylward; Belgium – 
H. Heidbuchel; Brazil – J.C. Nicolau; Bulgaria – A. Goudev; Canada – D. Roy, J. Weitz; Chile
– R. Corbalán; China – Y. Yang; Colombia – R. Botero; Croatia – M. Bergovec; Czech Republic
– J. Ŝpinar; Denmark – P. Grande, C. Hassager; Estonia – J. Voitk; Finland – H. Huikuri,
M. Nieminen; France – J.J. Blanc, J.Y. LeHeuzey; Germany – V. Mitrovic; Greece –
D. Alexopoulos; Guatemala – G. Sotomora; Hungary – R. Kiss; India – B. SomaRaju; Israel –
B. Lewis; Italy – P. Merlini, M. Metra; Japan – Y. Koretsune, T. Yamashita; Mexico –
A. García-Castillo; Netherlands – T. Oude Ophuis; New Zealand – H. White; Norway – D. Atar;
Peru – M. Horna; Philippines – N. Babilonia; Poland – W. Ruzyllo; Portugal – J. Morais;
Romania – M. Dorobantu; Russian Federation – M. Ruda; Serbia – M. Ostojic; Slovakia –
T. Duris; South Africa – A. Dalby; South Korea – N. Chung; Spain – J.L. Zamorano; Sweden –
S. Juul-Möller; Switzerland – T. Moccetti; Taiwan – S.A. Chen; Thailand – P. Sritara; Turkey –
A. Oto; Ukraine – A. Parkhomenko; United Kingdom – R. Senior.
Data Monitoring Committee: F. Verheugt (Chair), A. Skene (Statistician), J. Anderson, 
K. Bauer, J.D. Easton, S. Goto.
Clinical Events Committee: S. Wiviott (Chair), C. Lowe (Director), E. Awtry, C.J. Berger, 
K. Croce, A. Desai, E. Gelfand, W. Goessling, N.J. Greenberger, C. Ho, D.E. Leeman,
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3Participating Countries, Centers, and Investigators (National Lead Investigator in Bold) 
Argentina-  1059 subjects 58 centers 
O Vogelmann, C Gonzalez, Hospital de Alta Complejidad Presidente Juan Domingo Peron, 
Formosa, FOR; R Ahuad Guerrero, M Rodriguez, Corporación Médica de Gral. San Martín S.A., 
San Martin, BUE; J Albisu, E Rosales, Instituto Cardiovascular de San Luis, San Luis, SLS; O 
Allall, M Reguero, Hospital Cordoba, Cordoba, CRD; C Alvarez, M Garcia, Hospital Italiano 
Regional del Sur, Bahia Blanca, BUE; S Ameriso, P Ameriso, Instituto de Investigaciones 
Neurologicas Raul Carrea FLENI, Capital Federal, BUE; M Amuchastegui, M Caceres, Hospital 
Privado Centro Médico de Córdoba, Cordoba, CRD; J Beloscar, J Petrucci, Hospital Provincial 
del Centenario, Rosario, SFE; M Berli, M Berli, Cedir, Santa Fe, SFE; N Budassi, M Valle, 
Hospital Interzonal General de Agudos Dr Jose Penna, Bahia Blanca, BUE; G Bustamante 
Labarta, M Saravia, Sanatorio Nuestra Señora del Rosario, San Salvador de Jujuy, JUJ; A 
Caccavo, V Fracaro, Clinica Coronel Suarez, Coronel Suarez, BUE; L Cartasegna, V Novas, 
Hospital Italiano de La Plata, La Plata, BUE; O Caruso, R Saa Zarandon, Hospital Central 
Mendoza, Mendoza, MEN; H Colombo, M Morandini, Clinica Colombo, Cordoba, CRD; J 
Cuello, M Rosell, Instituto de Investigaciones Clinicas - Bahia Blanca, Bahia Blanca, BUE; C 
Cuneo, M Bocanera, Hospital San Bernardo, Salta, SAL; A D´Amico, G Cendali, Cedim Clínica 
Privada, Ramos Mejia, BUE; R Dran, V Moreno, Centro de Salud Norte, Munro, Buenos Aires, 
BUE; C Estol, M Davolos, STAT Research, Ciudad Autonoma de Bs. As., CBA; A Facello, M 
Facello, Centro Privado de Tomografia Computada Cordoba S.A., Cordoba, CRD; E Falu, M 
Iriarte, Sanatorio del Carmen, Salta; F Femenia, M Arrieta, Hospital Español de Mendoza, 
Godoy Cruz, MEN; J Fuselli, A Zanotti, Cemic Saavedra, Ciudad Autonoma de Bs. As., CBA; J 
Gant Lopez, F Meiller, Hospital Aleman, Ciudad Autonoma de Bs. As., CBA; R Garcia Duran, 
D Perlo, Instituto de Investigaciones Clinicas San Nicolas, San Nicolas, BUE; M Garrido, C 
Ceirano, Clínica Privada Provincial S.A., Merlo Buenos Aires, BUE; G Giacomi, M Eden, 
Unidad de Cardiologia Clinica, Mar del Plata, BUE; R Giannaula, M Huerta, Hospital Español, 
Buenos Aires, CBA; R Goicoechea, M von Wulffen, Hospital Jose Maria Ramos Mejia, Capital 
Federal, BUE; M Hominal, M Bianchini, Centro de Investigaciones Clinicas del Litoral SRL, 
Santa Fe, SFE; H Jure, D Jure, Clinica Chutro SRL, Cordoba, CRD; R Kevorkian, F Monaco, 
Hospital General de Agudos Donacion Francisco Santojanni, Capital Federal, CBA; G 
Lanternier, M Belcuore, Azira Clinical Research, Pergamino, BUE; G Liniado, M Iglesias, 
ALPI-Inst. de Rehabilitacion Marcelo Fitte, C.A.B.A., BUE; B Litvak, A Nigro, Servicios 
Hospitalarios San Justo S.A., Buenos Aires, BUE; J Llanos, S Vignau, Instituto de 
Investigaciones Clinicas de Rosario, Rosario, SFE; C Lorente, K Shatsky, Sanatorio Julio Corzo, 
Rosario, SJN; J Lotti, G Raimondi, Sanatorio Plaza, Rosario, SFE; I Mackinnon, M Carne, 
Instituto de Investigaciones Clínicas-Mar del Plata, Mar del Plata, BUE; O Manuale, M 
Calderon, Hospital Britanico de Buenos Aires, Capital Federal, CBA; J Marino, I Funes, Centro 
Medico Alcorta, Ciudad Autonoma de Bs. As., CBA; J Muntaner, H Gandur, Centro Mod de 
Cardiologia, San Miguel de Tucuman; D Nul, E Verdini, Clinica Constituyentes, Moron, BUE; 
D Piskorz, A Tommasi, Sanatorio Britanico S.A., Rosario, SFE; G Povedano, E Casares, 
Complejo Medico de la PFA Churruca Vizca, CABA, CBA; D Pozzer, E Fernandez, Inst. de 
Cardiología de Corrientes Juana Francisca Cabral, Corrientes, COR; A Prado, C Venturini, Inves 
Clinicas Tucuman, San Miguel de Tucuman, TUC; H Ramos, S Navarrete, Clinica Privada 
Caraffa, Cordoba, CRD; M Rodriguez, M Alvarez, Clinica y Maternidad Colon SA, Mar del 
Plata, BUE; A Sanchez, L Bowen, Instituto Investigaciones Clínicas Cipolletti, Cipolletti, RIO; 
M Sanjurjo, O Codutti, Cordis-Instituto del Corazón, Resistencia, CHA; S Saravia Toledo, I 
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4Medico Aguero, Moron, BUE; P Schygiel, C Buzzetti, Clinica Instituto Medico Adrogue, 
Adrogue, BUE; P Severino, P Morara, Clinica Independencia, Munro, BUE; M Sosa Liprandi, M 
Teves, Sanatorio Guemes, Ciudad Autonoma de Bs As, BUE; M Vico, Y Morell, Instituto 
Investigaciones Clinicas Zarate, Zarate, BUE.  
Australia-  102 subjects 13 centers 
C Anderson, T Paraskevaidis, Royal Prince Alfred Hospital, Camperdown NSW, NSW; M 
Arstall, B Hoffmann, Lyell McEwin Hospital, Elizabeth Vale, SA; D Colquhoun, S Price-Smith, 
Core Research Group, Milton, QLD; D Crimmins, A Slattery, Central Coast Neuroscience 
Research, East Gosford, NSW; A Dart, S Kay, Baker Heart Research Institute, Melbourne, VIC; 
S Davis, G Silver, Royal Melbourne Hospital, Parkville, VIC; S Flecknoe-Brown, J Roberts, 
Broken Hill Hospital, Broken Hill, NSW; P Gates, S Jones, Geelong Hospital, Geelong, VIC; R 
Lehman, H Morrison, Adelaide Medical Research, Ashford, SA; M McKeirnan, J Li, Brisbane 
South Clinical Research Centre, Carina Heights, QLD; V Paul, C Batta, Royal Perth Hospital, 
Perth, WA; P Purnell, L Perrett, Joondalup Cardiovascular Trials Foundation, Joondalup, WA; G 
Szto, V O'Shea, Peninsula Private Hospital, Frankston, VIC. 
Belgium-  149 subjects 15 centers 
L Capiau, F Banaeian, Wetteren; J De Bleecker, K de Koning, AZ Sint-Lucas, Gent; M De 
Tollenaere, L De Bruyne, Sint Augustinuskliniek, Veurne; P Desfontaines, G Tincani, CHC - 
Cliniques de l'Espérance, Montegnée; H Heidbuchel, K Meeusen, UZ Leuven, Leuven; J 
Herzet, D Malmendier, Centre Hospitalier Régional de la Citadelle (Psychiatry), Liege; G 
Mairesse, M Raepers, Clinique Saint-Joseph, Arlon; J Parqué, N Clinckemaille, Parqué Jean-
Luc, Mouscron; C Scavée, D Huyberechts, Cliniques Universitaires Saint-Luc, Bruxelles; D 
Stockman, C Jacobs, ZNA Middelheim, Antwerpen; Y Vandekerckhove, K Derycker, A.Z St. 
Jan, Brugge; J Vanwelden, J van Welden, A.Z Jan Palfijn, Merksem; G Vervoort, I Mestdagh, 
AZ Sint-Maarten - Campus Leopoldstraat, Mechelen; M Vrolix, C Beerts, Z.O.L - Campus St. 
Jan, Genk; B Wollaert, D Denie, ZNA Stuivenberg, Antwerpen. 
Brazil-  707 patients 37 centers 
A Amato Vincenzo de Paola, E Coutinho, Universidad Federal de Sao Paulo - UNIFESP, Sao 
Paulo, SP; P Andrade Lotufo, R Ferreira de Melo, Hospital Universitário da FMUSP, Sao Paulo, 
SP; J Atie, C Motta, SMO Brazil, Rio de Janeiro, RJ; F Augusto Alves da Costa, R Franchin 
Ferraz, FGM Clin Paulista de Doenças Cardiov LTDA, São Paulo, SP; D Bertolim Precoma, E 
Sehnem, Hospital Angelina Caron, Campina Grande do Sul, PR; R Botelho, S Cunha, Instituto 
do Coração do Triângulo Mineiro, Uberlândia, MG; R Brondani, N Fleck, Hospital das Clinicas 
de Porto Alegre, Porto Alegre, RS; H Chaves Junior, J Silva, Hospital as Clinicas da 
Universidade Federal de Pernambuco, Recife, PE; C Costantini, D Barroso, Hospital 
Cardiologico Costantini, Curitiba, PR; M De Patta, V Pereira, Instituto de Cardiologia de Santa 
Catarina, San Jose, SC; N Duda, R Laimer, Hospital Sao Vicente de Paulo, Passo Fundo, RS; O 
Dutra, S Morgado, Instituto de Cardiologia do Rio Grande do Sul, Porto Alegre, RS; W Faustino 
Saporito, M Seroqui, Hospital Estadual Mario Covas- SP, Santo Andre, SP; L Ferreira, E Araújo, 
Instituto de Cardiologia do Distrito Federal, Brasilia, DF; H Finimundi, C Daitz, Instituto de 
Pesquisa de Estudos Multicentricos, Caxias do Sul, RS; R Gagliardi, G Pereira, Santa Casa de 
Misericordia de Sao Paulo, Sao Paulo, SP; M Gomes, A Gomes, Clinicor - Hospital do Coracao 
de Alagoas, Maceio, AL; A Guimarães, L Ninho, Hospital Geral de Bonsucesso, Rio de Janeiro, 
RJ; C Jaeger, L Pereira, Hospital Mae de Deus, Porto Alegre, RS; J Jorge, C Cury, Santa Casa de 
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5Janeiro, RJ; C Kalil, G Radaelli, Hospital Sao Lucas - PUCRS, Porto Alegre, RS; W Kunz Sebba 
Barroso de Souza, K Morales, Via Médica - Centro Clinico, Goiania, GO; P Leaes, R Osorio 
Luiz, Santa Casa de Porto Alegre, Porto Alegre; J Pimenta Almeida, A Gozalo, Hospital do 
Servidor Publico Estadual de Sao Paulo, Sao Paulo, SP; G Reis, K Avellar, Santa Casa de 
Misericordia de Belo Horizonte, Belo Horizonte, MG; L Reis Katz Weiand, J Leipelt, Hospital 
Bruno Born, Lajeado, RS; J Rocha, R Barros, Hospital Centro Medico de Campinas, Campinas, 
SP; L Rodrigues, M Rubia Rocha, Encore Cardiologia e Radiologia Intervencionista, Aparecida 
de Goiânia, GO; A Rodrigues, D Rodrigues, ICM - Instituto do Coracao de Marilia, Marilia, SP; 
F Rossi dos Santos, L Goncalves Pagnan, Loema - Instituto de Pesquisa Clinica, Campinas, SP; 
R Sampaio, R do Val, Instituto do Coracao - Incor, Sao Paulo, SP; J Saraiva, C Vicente, Hospital 
e Maternidade Dr. Celso Pierro - PUC Campinas, Campinas, SP; M Simoes, A Carraro, Hospital 
das Clinicas da FMRP, Ribeirao Preto, SP; D Sobral Filho, E Lustosa, PS de Cardiologia de 
Pernambuco (PROCAPE) Univ de Pernambuco, Recife, PE; F Villas Boas, M Almeida, Hospital 
Espanhol, Salvador, BA; S Zimmermann, E Bürger Zimmermann, Clinica Procardio, Blumenau, 
SC. 
Bulgaria-  520 patients 17 centers 
B Chompalova, G Parishev, MHAT - Plovdiv AD, Plovdiv; S Denchev, N Milcheva, UMHAT 
Alexandrovska EAD, Sofia; T Donova, V Gergova, UMHAT Alexandrovska EAD, Sofia; B 
Georgiev, E Kostova, MHAT-National Heart Hospital EAD, Sofia; A Goudev, E Kinova, 
UMHAT Tzaritza Yoanna - ISUL EAD, Sofia; V Hergeldjieva, P Kamenova, MHAT - Ruse 
AD, Ruse; A Manolova, I Vasilev, MHAT - Haskovo AD, Haskovo; A Mihov, B Miteva, 
MHAT Sveta Ekaterina EOOD, Dimitrovgrad; V Mincheva, V Stoyanovski, UNMTHAT Tzar 
Boris III - Sofia, Sofia; F Nikolov, D Vasilev, UMHAT Sv. Georgi EAD, Plovdiv; G Pencheva, 
K Kostov, Fourth MHAT- Sofia AD, Sofia; S Petranov, T Milusheva, MHAT – Burgas AD, 
Burgas; A Popov, I Vasilev, Diagnostic Consultative Center Sveti Georgi EOOD, Haskovo; A 
Staneva, D Momchilova- Lozeva, Central Clinical Base-Medical Institute-MI, Sofia; G Todorov, 
M Nyagina, Second MHAT- Sofia AD, Sofia; H Tumbev, D Tumbeva, DCC Chaika EOOD, 
Varna; M Tzekova, M Kitova, E Manoylov, UMHAT Dr. Georgi Stranski EAD, Pleven. 
Canada-  774 patients 54 centers 
J Archibald, S Antle, Pharmaceutical Integrated Research Company, Halifax, NS; R Bhargava, C 
Stafford, Heart Care Research, Oshawa, ON; S Bose, M Hundseth, Dr. S. Bose Medical 
Profession Corporation, North Saskatoon, SK; J Cha, J Otis, Oshawa Medical Arts Building, 
Oshawa, ON; R Chehayeb, C Lepage, Greenfield Park, QC; M Chilvers, L Vansickle, Sarnia 
Research Institute, Sarnia, ON; D Cleveland, S Valley, Penticton Regional Hospital, Penticton, 
BC; C Constance, M Gauthier, Clinique Santé Cardio MC, Montreal, QC; P Costi, C Masson, 
CSSS du Sud de Lanaudière- Hôpital Pierre-Le Gardeur, Terrebonne, QC; B Coutu, I Denis, 
CHUM- Hôtel-Dieu, Montréal, QC; M du Preez, A Kubanska, The Medical Arts Health 
Research Group, Kamloops, BC; M Dufresne, J Krider, Trainyards Health and Wellness Center, 
Ottawa, ON; J Eikelboom, M Zondag, Hamilton General Hospital, Hamilton, ON; C Fortin, C 
Viau, Neufort Incorporated, Saint-Lambert, QC; M Green, D Houbraken, University of Ottawa 
Heart Institute, Ottawa, ON; R Hatheway, J Mabee, Pharmaceutical Integrated Research 
Company, Bridgewater, NS; J Heath, L Scott, Alder Medical Centre, Campbell River, BC; K Ho, 
V Ho, Chilliwack, BC; G Hoag, R Standring, Discovery Clinical Services Limited, Victoria, BC; 
T Huynh, L Perkins, The Montreal General Hospital, Montreal, QC; S Kouz, M Roy, Centre 
Hospitalier Régional de Lanaudière, St.-Charles-Borromee, QC; R Labonte, C Dewar, Dr. R 
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6d'investigation clinique de la Mauricie, Trois-Rivières, QC; S Lam, H Lam, Calgary West 
Medical Centre, Calgary, AB; T Lichtenstein, P Roberts, The Medical Arts Health Research 
Group, Kelowna, BC; R Luton, S Douglas, London, ON; P Ma, M Seib, Heart Health Institute, 
Calgary, AB; C MacCallum, J Matthews, Eastern Health, St. John's, NL; P Malette, T 
Vaillancourt, Medicor Research Incorporated, Sudbury, ON; C Maranda, E Studenikow, 
Cardiology and Research, Westmount, QC; A Mawji, A Morely, Pharmaceutical Integrated 
Research Company, London, ON; D Morrison, M Roth, Beamsville Medical Centre, Beamville, 
ON; M Mucha, J Krider, Trainyards Health and Wellness Center, Ottawa, ON; A Najarali, U 
Lamoureux, PIRC Research Office- Brampton, Brampton, ON; R Nicholson, A Morely, 
Pharmaceutical Integrated Research Company, Kitchener, ON; G O'Hara, P Banville, Quebec 
Heart Institute, Quebec City, QC; W O'Mahony, R Bolton, Corunna Medical Research Center, 
Corunna, ON; R Parkash, L Carroll, Queen Elizabeth II Health Sciences Centre, Halifax, NS; Y 
Pesant, V Sardin, Recherche Médicale St-Jérôme Incorporated, St-Jérôme, QC; P Polasek, L 
Turri, Kelowna Cardiology Research, Kelowna, BC; A Qureshi, C Nethercott, PIRC Research 
Office- Brampton, Listowel, ON; J Ricci, B Bozek, Scarborough Cardiology Research, 
Scarborough, ON; D Rupka, C Marchand, Fraser Clinical Trials Incorporated, New Westminster, 
BC; D Shu, G Silverio, Gain Medical Centre, Coquitlam, BC; R St-Hilaire, A Morissette, Centre 
Hospitalier Beauce-Etchemin, Saint-Georges, QC; J Sussman, P Kailey, Toronto, ON; G Syan, C 
Bobbie, G.S. Cardiac Lab Medicine Professional Corp., Sudbury, ON; M Talajic, D David, 
Montreal Heart Institute, Montreal, QC; P Talbot, M Tremblay, Centre de Recherche Clinique de 
Québec, Québec, QC; I Teitelbaum, J Teitelbaum, JJ Dig Research, Toronto, ON; G Velthuysen, 
L Giesbrecht, Holley Clinic, Quesnel, BC; R Wahby, A Morley, Dorchester Medical Center, 
Dorchester, ON; S Wharton, T Caterini, The Wharton Medical Clinic Clinical Trials, Hamilton, 
ON; T Woodford, J Mabee, Pharmaceutical Integrated Research Company, Liverpool, NS. 
Chile-   254 patients 14 centers 
W Balboa, L Retamal Matus, Hospital Victoria, Victoria; C Bugueño, P Mondaca Mondaca, 
Hospital San Juan de Dios La Serena, La Serena; J Cobos, C Obreque, Hospital El Pino, 
Santiago; R Corbalan, A Parada, Hospital Clinico Pontificia Universidad Catolica de Chile, 
Santiago; F Florenzano, P Arratia Diaz, Hospital del Salvador, Santiago; M Lopetegui, C 
Rebolledo, Hospital San Borja Arriaran, Santiago; L Manriquez, L Manríquez Silva, Hospital 
Regional de Rancagua, Rancagua; D Martinez,R Romero Llamas, Clinica Iquique, Iquique; M 
Opazo, M Carmona Pérez, Hospital Naval Almirante Nef, Viña del Mar; C Pincetti, G Torres 
Carrasco, Centro de Investigacion Clinica del Sur, Temuco; S Potthoff, J Zapata Staub, 
Corporacion de Beneficencia Osorno, Osorno; M Rodriguez, Y Campisto, Hospital Dr. Sotero 
del Rio, Santiago; B Stockins, C Lara Lara, Hospital Dr. Hernan Henriquez Aravena, Temuco; P 
Yovaniniz, M Grandon Azua, Hospital Barros Luco Trudeau, Santiago. 
China-  469 patients 33 centers 
F Bai, GL Xu, The Second Hospital of Lanzhou University, Lanzhou;  JZ Chen, XD Xie, The 
First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou;  XP Chen, X 
Zhang, West China Hospital, Sichuan University, Chengdu;  YG Dong, C Feng, The First 
Affiliated Hospital of Sun Yat-sen University, Guangzhou;  GS Fu, P Zhang, Sir Run Run Shaw 
Hospital, School of Medicine, Zhejiang University, Hangzhou;  K Hong, ZG You, The Second 
Affiliated Hospital of Nanchang University, Nanchang;  L Hong, Y Qiu, Renmin Hospital of 
Jiang Xi Province, Nanchang;  XJ Jiang, Z Qu, Ren Min Hospital of Wu Han University, 
Wuhan;  L Li, H Liu, The First Affiliated Hospital of Guangxi Medical University, Nanning;  TF 
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71st Affiliated Hospital of Harbin Medical University, Harbin;  ZQ Li, Y Liu, People's Hospital of 
Liaoning Province, Shenyang;  DN Liao, XJ Gu, Changzheng Hospital, The Second Military 
Medical University, Shanghai;  L Liu, ZH Lu, The People’s Hospital of Guangxi Zhuang 
Autonomous Region, Nanning;  SM Ma, ZY Yang, Shengjing Hospital of China Medical 
University, Shengyang;  DM Wang, SY Qi, Bethune International Peace Hospital, Shijiazhuang; 
GP Wang, XJ Shi, The First Hospital Affiliated to Liaoning Medical College, Jinzhou;  M Wei, 
D Huang, Shanghai No.6 People's Hospital, Shanghai;  SL Wu, YE Li, Guangdong Provincial 
People's Hospital, Guangzhou;  JH Xu, JY Gu, Tong Ji Hospital of Tongji University, Shanghai; 
YM Xu, YZ Liang, The 2nd Hospital of Tianjin Medical University, Tianjin;  K Yang, AY Li, 
The Third Xiangya Hospital of Central South University, Changsha;  YJ Yang, X Zheng, 
Cardiovascular Institute & Fuwai Hospital Chinese Academy of Medical Sciences, Beijing;  Y 
Zheng, M Gao, The First Hospital of Jilin University, Changchun;  YH Yin, YP Xu, The Second 
Affiliated Hospital of Chongqing Medical University, Chongqing;  B Yu, LL Li, The 2nd 
Affiliated Hospital  of Harbin Medical University, Harbin;  ZY Yuan, H Qiang, The 1st Hospital 
Affiliated to Xi'an Medical University, Xian;  HQ Zhang, YN Lin, The 1st Affiliated Hospital of 
Wenzhou Medical College, Wenzhou;  Z Zhang, H Kang, The 1st Hospital Affiliated to Lanzhou 
University, Lanzhou;  RP Zhao, RJ Han, Baotou Central Hospital, Baotou;  XL Zhao, JQ Wang, 
Beijing Tong Ren Hospital Affiliated to Capital Medical University, Beijing;  ZQ Zheng, BG Li, 
The First Affiliated Hospital of NanChang University, Nanchang;  SX Zhou, YL Zhang, The 
Second Affiliated Hospital of Zhongshan University, Guangzhou. 
Colombia-  141 patients 11 centers 
J Accini, M Accini, Consultorio Privado-Jose Luis Accini, Baranquilla; N Cano, L León Pineda, 
Hospital Santa Sofia, Manizales; J Delgado Restrepo, C Arroyave, Instituto Corbic, Medellín; R 
Fernández Ruiz, I Aldana Diaz, Clinica Cardiovascular Santa Maria, Medellin; H Hernandez, P 
Delgado, Instituto Corazon de Bucaramanga, Bucaramanga; C Jaramillo Muñoz, A Builes, 
Promotora Medica Las Americas SA, Medellin; F Manzur, E Rivera Rodriguez, Centro de 
diagnostico cardiologico Ltda, Cartagena; M Moncada Corredor, D Lopez Giraldo, Fundacion 
Centro de Investigacion Clinica CIC, Medellín; L Orozco Linares, J Fonseca, Foqus LTDA, 
Bogotá Cundinamarca; A Quintero, C Gonzales, Fundación del Caribe para la Investigación 
Biomédica, Barranquilla; G Sanchez Vallejo, I Perdomo Mejia, Centro de Estudios Clinicos del 
Quindio, Armenia. 
Croatia-  127 patients 11 centers 
J Bagatin, V Carevic, Clinical Hospital Centre Split, Split; S Car, M Jeric, General Hospital 
Varazdin, Varazdin; N Ciglenecki, S Tusek, Special Hospital for Medical Rehabilitation, 
Krapinske Toplice; J Ferri Certic, I Romic, General Hospital Dubrovnik, Dubrovik; I Francetic, 
K Makar Ausperger, University Hospital Center Zagreb, Zagreb; V Jelic, S Jaksic Jurinjak, 
General Hospital Karlovac, Karlovac; A Knezevic, B Buksa, General Hospital Zadar, Zadar; P 
Samardzic, K Cvitkusic Lukenda, General Hospital Dr. J. Bencevic, Slavonski Brod; R Steiner, 
D Kirner, Clinical Hospital Osijek, Osijek; K Sutalo, Z Bakliza, General Hospital Dr.Tomislav 
Bardek, Koprivnica; H Vrazic, M Bergovec, T Lucijanic, University Hospital Dubrava, Zagreb. 
Czech Republic-  1173 patients 39 centers 
M Bar, P Brodova, Neurologicka ambulance Bormed, Ostrava- Trebovice; L Berka, V 
Kunkelova, Ordinace pro choroby srdce a cev, Jindrichuv Hradec; M Brtko, M Brtko, Fakultni 
nemocnice Hradec Kralove, Hradec Kralove; H Burianova, H Burianova, Poliklinika Humanitas, 
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ordinace, Brno- Lesna; R Ferkl, R Ferkl, Interni ambulance, Trutnov; J Florian, J Florian, 
Nemocnice Cesky Krumlov, Cesky Krumlov; L Francek, L Francek, Kromerizska nemocnice 
a.s., Kromeriz; L Golan, L Golan, Kardiologie, Revnice; P Gregor, P Gregor, Fakultni 
nemocnice Kralovske Vinohrady, Praha; M Honkova, M Honkova, Kardiologicka a interni 
ambulance, Praha 1; J Hubac, J Hubac, Interni ambulance, Chrudim; J Jandik, J Jandik, Oblastni 
nemocnice Nachod, Nachod; P Jarkovsky, P Jarkovsky, Ustredni vojenska nemocnice Praha, 
Praha 6; Z Jelinek, Z Jelinek, Nemocnice Hranice a.s., Hranice; O Jerabek, O Jerabek, 
Poliklinika RAVAK, Pribram 8; R Jirmar, R Jirmar, Poliklinika Malešice, Praha 10; R Kobza, R 
Kobza, Mediscan s.r.o., Praha 11; M Kochrt, G Kostkova, Interni ordinace, Teplice; Z Kosek, Z 
Kosek, Kardiologicka ambulance, Mlada Boleslav; P Kovar, P Kovar, Poliklinika Modrany, 
Praha 4; R Kuchar, R Kuchar, INNEra s.r.o., Benesov; J Kvasnicka, J Kvasnicka, Kardiologicka 
ambulance, Praha 10; O Ludka, O Ludka PhD., Privatni interni ambulance, Brno; V Machova, E 
Krocova, InterKardioML s.r.o., Marianske Lazne; M Melichar, M Melichar, Interni ambulance, 
Pardubice; R Nechanicky, R Nechanicky, Nemocnice s poliklinikou Semily, Semily; J Olsr, J 
Olsr, General practitioner s.r.o., Ostrava; K Peterka, K Peterka, Nemocnice Havlickuv Brod p.o., 
Havlickuv Brod; I Petrova, I Havlova, Kardiologicka ambulance, Usti nad Labem; J Pisova, J 
Pisova, Kardiologicka ambulance, Hradec Kralove; P Podrazil, E Jirsova, Interni ambulance, 
Praha 6; P Reichert, P Reichert, Krajska zdravotni a.s.Nemocnice Teplice p.o., Teplice; J Slaby, 
J Slaby, Oblastni nemocnice Kolin, Kolin; R Spacek, R Spacek, Nemocnice Na Frantisku, Praha 
1; J Spinar, R Labrova, FN Brno- Bohunice, Brno; P Vodnansky, D Samkova, Kardiologicka 
ordinace, Pardubice; E Zidkova, E Zidkova, Ordinace interniho lekarstvi, Praha 5. 
 
Denmark-  219 patients 11 centers 
K Dodt, Horsens Sygehus, Horsens; H Christensen, L Christensen, Bispebjerg Hospital, 
København NV; C Hassager, A Loof, Rigshospitalet, København Ø; H Ibsen, H Madsen, 
Holbæk Sygehus, Holbæk; H Iversen, T Veng-Olsen, Glostrup Hospital, Glostrup; H Nielsen, R 
Olsen, Bispebjerg Hospital, København NV; K Overgaard, V Petrovic, Herlev Hospital, Herlev; 
I Raymond, D Raae, Frederiksberg Hospital, Fredriksberg; N Sand, A Svenningsen, Sydvestjyds 
Sygehus Esbjerg, Esbjerg; C Torp-Pedersen, U Jakobsen, Gentofte Hospital, Hellerup; H 
Wiggers, K Serup-Hansen, Skejby Sygehus- Aarhus University Hospital, Aarhus N. 
 
Estonia-  191 patients 6 centers 
J Kaik, A Stern, Fertilitas AS, Haabneeme; R Kolk, R Kolk, Tartu University Hospital, Tartu; E 
Laane, L Rivis, Orthopaedic and Clinical Research Center, Tartu; M Paumets, J Voitk, M 
Laheäär, North Estonia Medical Centre Foundation, Talinn; A Rosenthal, R Rajasalu,Tallinn; V 
Vahula, E Ratnik, Pärnu Hospital, Pärnu. 
 
Finland-  42 patients 7 centers 
H Huikuri, S Kaarleenkaski, Oulun yliopistollinen sairaala, Oulu; E Hussi, S Valpas, Etelä-
Karjalan keskussairaala, Lappeenranta; P Jäkälä, T Lappalainen, Itä-Suomen yliopisto Kuopion 
kampus Kliininen tutkimuskesk, Kuopio; A Mäenpää, J Viitaniemi, Seinäjoen keskussairaala, 
Seinäjoki; K Nyman, T Sankari, Keski-Suomen keskussairaala, Jyväskylä; H Rasi, O Salminen, 
Terveystalo Tampere, Tampere; V Virtanen, H Nappila, Finn-Medi 1, Tampere. 
 
France-  110 patients 14 centers 
J Le Heuzey, Hôpital Européen Georges Pompidou, Paris, 75; B Agraou, F El Jarroudi, Centre 
Hospitalier Général, Valenciennes, 59; P Amarenco, P Boursin, Hopital Bichat, Paris, 75; D 
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9Hospitalier de Cambrai, Cambrai, 59; H Berbari, H Berbari, Hopital d'Instruction des Armees 
Percy, Clamart Cedex, 92; J Blanc, P Dias, Chu de Brest- Hôpital de la Cavale Blanche, Brest 
Cedex, 29; D Coisne, N Berger, Chu Poitiers- Hôpital de la Milètrie, Poitiers, 86; E Decoulx, M 
El Jarroudi, CH Chatiliez Tourcoing, Tourcoing, 59; S Dinanian, M Arfaoui, Hopital Antoine 
Beclere, Clamart, 92; J Hermida, E Deruche, Centre Hospitalier Sud, Amiens, 80; S Kacet, S 
Corbut, Hospital Cardiologique Chru Lille, Lille Cedex, 59; J Poulard, S Leparree, Centre 
Hospitalier d'Abbeville, Abbeville, 80; R Roudaut, C Duprat, Hôpital du Haut l'Eveque 
(Cardiologie), Pessac, 33. 
Germany-  913 patients 55 centers 
A Al-Zoebi, A Wurow, Kardiologische Praxis, Wermsdorf, SN; P Bernhardt, U Dichristin, 
Universitaetsklinikum Ulm, Ulm, BW; J Berrouschot, S Vierbeck, Klinikum Altenburger Land, 
Altenburg, TH; J Beyer-Westendorf, B Sehr, Universitaetsklinikum Dresden, Dresden, SN; M 
Bouzo, P Schnelzer, Muenchen, BY; R Braun, K Ladenburger, Unterschneidheim, BW; M Buhr, 
D Weihrauch, Kardiologische Praxen im Spreebogen, Berlin, BE; C Contzen, M Kara, Synexus 
ClinPharm International GmbH, Frankfurt, HE; W Daut, D Ayasse, Kallstadt, RP; E Degtyareva, 
P Kranz, Synexus ClinPharm International GmbH, Leipzig, SN; T Drescher, B Herfurth, 
Gemeinschaftspraxis, Stuhr, HB; M Faghih, M Faghih, Hausarztzentrum, Essen, NW; K Forck-
Boedeker, K Schneider, pro scientia med, Luebeck, SH; R Fuchs, W Manuela, Orgamed System 
Fuchs & Partner KG, Giengen, BW; C Grigat, A Otto, Clinical Research Hamburg GmbH, 
Hamburg, HH; A Hartmann, M Peitz, Klinikum St. Georg Leipzig, Leipzig, SN; H Heuer, U 
Dieckheuer, St. Johannes Hospital- PS, Dortmund, NW; U Hoffmann, S Dorn, 
Universitaetsklinikum Mannheim, Mannheim, BW; S Hoffmann, M Schuppe, Vivantes 
Klinikum im Friedrichshain, Berlin, BE; T Horacek, P Fink, Evangelisches Krankenhaus, 
Witten, NW; J Junggeburth, S Schmid, Bad Woerrishofen, BY; W Jungmair, B Schoen, 
Kardiologische Praxis, Bad Homburg, HE; U Kleinecke-Pohl, P Meusel, Gemeinschaftspraxis 
Kleinecke-Pohl Kirsch Benner-Hemsen, Koeln, NW; H Koenig, F Bauch, Synexus Clinical 
Research GmbH, Berlin, BE; H Koenig, F Bauch, Synexus ClinPharm International GmbH, 
Potsdam, BR; I Lohrbaecher-Kozak, B Grosse, Synexus Clinical Research GmbH, Dresden, SN; 
S Lueders, U Venneklaas, St. Josefs-Hospital, Cloppenburg, NI; M Luttermann, M Wulf, 
Wardenburg, NI; O Maus, K Hoefer, Innomed Leipzig GmbH, Leipzig, SN; G Meissner, U 
Braemer, Synexus ClinPharm International GmbH, Magdeburg, ST; U Meyer-Pannwitt, E 
Frahm, Mare Klinikum, Kiel, SH; V Mitrovic, S Vogt, Kerckhoff Klinik GmbH, Bad Nauheim, 
HE; A Muegge, S Barbera, St. Josef-Hospital- PS, Bochum, NW; M Mueller-Glamann, K 
Raddatz, Gemeinschaftspraxis Drs. Krohn/Mueller-Glamann, Hamburg, HH; R Piechatzek, D 
Lewinsky, Synexus ClinPharm International GmbH, Goerlitz, SN; W Pohl, W Pohl, 
Gemeinschaftspraxis Dr. Al-Nakkash Dr. W. Pohl Dr. C Pohl, Dresden, SN; N 
Proskynitopoulos, M Kuhlmann, Gemeinschaftspraxis, Nienburg, NI; K Rack, H Pilipenko, 
Internistische Praxis, Augsburg, BY; A Rinke, A Kühlenborg, Synexus ClinPharm International 
GmbH, Bochum, NW; A Schaefer, N Szymanowski, Essen, NW; S Schellong, R Frommhold, 
Staedtisches Klinikum Dresden-Friedrichstadt, Dresden, SN; I Schenkenberger, T Finsterbusch, 
K Dreykluft, Klinische Forschung Berlin, Berlin, BE; C Schiewe, C Schiewe, Hamburg, HH; A 
Schmidt, M Schmidt, Offenbach, HE; A Schreckenberg, J Hellmers, Internistische 
Praxisgemeinschaft, Weyhe, NI; H Seibert, G Gold, Kassel, HE; H Sohn, M Baylacher, Ludwig-
Maximilians-Universitaet, Muenchen, BY; S Spitzer, K Bonin, Facharztzentrum Dresden-
Neustadt GBR, Dresden-Neustadt, SN; R Stoehring, R Stoehring, Kardiologische Praxis, Bad 
Homburg, HE; J Taggeselle, C Zarpentin, Markkleeberg, SN; R Veltkamp, I Ludwig, 
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Berlin Westend, Berlin, BE; K Weyland, Ingelheim, RP; B Winkelmann, B Buelow-Johansen, 
ClinPhenomics GmbH & Co. KG, Frankfurt, HE; C Wolde, K Winter, Heidelberg, BW. 
 
Greece-  51 patients 7 centers  
D Alexopoulos, E Mavronasiou, Patras University Hospital, Patra; P Bourlios, A Tziortziotis, 
General Prefectural Hospital of Trikala, Trikala; C Karamitsos, E Exarchou, General Hospital of 
Larissa, Larissa; K Kifnidis, A Daskalaki, General Hospital of Athens Asklipio Voulas, Athens; 
N Moschos, K Dimitra, General Hospital of Rhodes, Rhodes; C Olympios, E Kartsagkoulis, 
Genaral Hospital of Elefsina Attikis Thriasio, Athens; V Pyrgakis, K Korantanis, General 
Hospital of Athens G. Gennimatas, Athens. 
 
Guatemala-  136 patients 7 centers 
O Ayau Milla, V de Leon Ramirez, Zacapa; I Guzman Melgar, T Jimenez, Edificio Plaza 
Dorada, Guatemala City; A Ovando Lavagnino, S Guevara, Liga del Corazon, Guatemala City; 
M Rodas Estrada, T Jimenez, Clinica Privada Dr. Rodas Estrada, Guatemala City; M Sanchez, J 
Mayen Pozuelos, CardioQuetzal, Quetzaltenango; C Sanchez Samayoa, L Guerra, Clinicas 
Hospital Centro Medico, Guatemala City; L Velasquez Camas, S Padilla Almaraz, Unicar, 
Guatemala. 
 
Hungary-  464 patients 21 centers 
P Dioszeghy, E Muskoczki, Josa Andras Oktatokorhaz Egeszsegugyi Szolg. Nonprofit Kft., 
Nyiregyhaza; I Edes, J Szatmari, Debreceni Egyetem Orvos- es Egeszsegtudomanyi Centrum, 
Debrecen; J Fiok, A Varga, Sopron Medical SMO Erzsebet Korhaz, Sopron; N Kanakaridisz, M 
Kosztyu, UNO Medical Trials Kft., Budapest; E Kis, J Felfoldine Feil, Tolna Megyei 
Onkormanyzat Balassa Janos Korhaza, Szekszard; R Kiss, A Jakal, Honvedelmi Miniszterium 
Allami Egeszsegugyi Kozpont, Budapest; M Koczka, M Koczka, Mako; I Kovacs, M Baranyai, 
Vas Megyei Markusovszky Korhaz Nonprofit Zrt, Szombathely; Z Kovacs, Z Kovacs, Bajai 
Szent Rokus Korhaz, Baja; G Lupkovics, H Horvathne Karakai, Zala Megyei Korhaz, 
Zalaegerszeg; A Matoltsy, T Kiss, Kanizsai Dorottya Korhaz, Nagykanizsa; M Medvegy, K 
Kiss, Pest Megyei Flor Ferenc Korhaz, Kistarcsa; B Merkely, E Kolumban, Semmelweis 
Egyetem, Budapest; A Nagy, A Nagy, Bacs-Kiskun Megyei Onkormanyzat Korhaza, 
Kecskemet; A Palinkas, S Rostasne Toth, Erzsebet Korhaz-Rendelointezet, Hodmezovasarhely; 
A Sayour, A Bognar, Magyar Imre Korhaz, Ajka; T Simor, D Ruzsa, Pecsi Tudomanyegyetem 
Altalanos Orvostudomanyi Kar, Pecs; T Sipos, T Sipos, Rethy Pal Korhaz, Bekescsaba; I Szakal, 
I Szakal, Selye Janos Korhaz, Komarom; J Tomcsanyi, A Marosi, Budai Irgalmasrendi Korhaz, 
Budapest; A Vertes, M Kincses, Fov.Onk.Egyesitett Szt. Istvan es Szt Laszlo Korh.-Rend.Int., 
Budapest. 
 
India-   690 patients 65 centers 
S Malhan, Sheth Vadilal Sarabhai Hospital and Municipal Medical Colleg, Ahmedabad, Gujarat; 
J Abdullakutty, N.H., Lissie Hospital, Cochin, Kerala; D Agarwal, R Ranka, S. P. Medical 
College & Associated Group of Hospitals, Bikaner, Rajasthan; J Arneja, A Memon, Arneja Heart 
Institute, Nagpur, Mahara; V Arora, R Shree, Max Devki Devi Heart & Vascular Institute, New 
Delhi, Delhi; G Avvaru, A Shaikh, Yashoda Hospital, Hyderabad, Andh Prad; P Babu, B Rao, 
Dr. Ramesh Cardiac and Multi Speciality Hospital Ltd., Vijayawada, Andh Prad; R Babu, J 
Reddy, Medwin Hospital, Hyderabad, Andh Prad; D Banker, T Sheth, Banker’s Heart Institute, 
Vadodara, Gujarat; P Benjarge, S Surushe, Krishna Hospital & I. C. U., Aurangabad, Mahara; A 
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A Rathi, Care Hospital (Nagpur), Nagpur, Mahara; A Biniwale, M Bhuti, Biniwale Clinic, Pune, 
Mahara; N Calambur, B Somaraju, N Karnwal, Care Hospital, Hyderabad, Andh Prad; M 
Chopda, N Mali, Chopda Medicare & Research Centre, Nashik, Mahara; N Goyal, A Saini, 
Speciality Clinic, New Delhi, Delhi; J Gupta, P Singh, S. R. Kalla Memorial General Hospital, 
Jaipur, Rajasthan; S Hadan, P Savanth, Yenepoya Speciality Hospital, Mangalore, Karna; S 
Hardas, G Thakor, Ruby Hall Clinic, Pune, Mahara; J Hiremath, A Ghume, Poona Hospital and 
Research Centre, Pune, Mahara; R Jain, M Pahuja, CHL - Apollo Hospital, Indore, Madh Prad; S 
Joseph, D Oommen, Little Flower Hospital, Cochin, Kerala; J Joseph, R Thomas, Caritas 
Hospital, Kottayam, Kerala; H Joshi, Iby, Apollo Hospitals International Ltd., Gandhinagar, 
Gujarat; V Kale, N Raut, Lokmanya Hospital, Pune, Mahara; B Kandekar, S Kandekar, Nobel 
Hospital, Ahmednagar, Mahara; R Kishore, H Krishnan, Narayana Hrudayalaya Institute of 
Medical Sciences, Bangalore, Karna; V Kotiwale, V B, Kles's Dr. Prabhakar Kore Hospital and 
Med. Res. Centre, Belgaum, Karna; R Kulkarni, M Deokar, Moraya Multispeciality Hospital, 
Pune, Mahara; G Kulkarni, A Lawande, Shree Hospital, Pune, Mahara; P Kumar, M Karpuram, 
Osmania General Hospital, Hyderabad, Andh Prad; A Kumar, J Francis, Lakeshore Hospital and 
Research Centre, Cochin, Kerala; M Kumbla, A Anthony, Omega Hospital, Mangalore, Karna; P 
Lavhe, M Kale, Avanti Institute of Cardiology, Nagpur, Mahara; H Mardikar, P Bhaskarwar, 
Spandan Heart Institute, Nagpur, Mahara; A Mathur, P Sharma, Escorts Heart Institute & 
Research Centre, New Delhi, Delhi; J Menon, V Francis, Mar Augustine Golden Jubilee 
Hospital, Ernakulam, Kerala; D Namjoshi, S Shelke, Criti Care Hospital, Mumbai, Mahara; J 
Narendra, P J, S. A. T. Hospital, Shimoga, Karna; S Natarajan, V Francis, G. Kupuswami Naidu 
Memorial Hospital, Coimbatore, Tamilnadu; A Oomaan, P Gurusamy, Apollo Hospitals, 
Chennai, Tamilnadu; B P. R., J Angel, Frontier Lifeline & Dr. K.M. Cherian Heart Foundation, 
Chennai, Tamilnadu; M Padinhare Purayil, S Shams, West Fort Hi-Tech Hospital Ltd., Thrissur, 
Kerala; U Pandurangi, R Sababathi, Institute of Cardiovascular Diseases Madras Medical 
Mission, Chennai, Tamilnadu; P Parekh, B Jasani, Care Hospital, Surat, Gujarat; N Patki, A 
Babbar, Deenanath Mangeshkar Hospital and Research Centre, Pune, Mahara; B Pinto, H 
Kharalkar, Bandra Holy Family Hospital and Research Center, Mumbai, Mahara; R Premchand, 
H Jambula, Krishna Institute of Medical Sciences, Hyderabad, Andh Prad; M Rao, A Vuriya, 
Queen's NRI Hospital, Vishakhapatnam, Andh Prad; A Ravi Shankar, R E R, Mysore Medical 
College and Research Institute, Mysore, Karna; R Reddy, S Bekal, Mediciti Hospital, 
Hyderabad, Andh Prad; D Roy, A Barai, Rabindranath Tagore International Institute of Cardiac 
Scien, Kolkata, W Bengal; D Saha, R Gadepalli, Nizam's Institute of Medical Sciences, 
Hyderabad, Andh Prad; H Sant, D Jadhav, Medipoint Hospital Pvt Ltd , Pune, Mahara; M Sarna, 
T Arora, Monilek Hospital and Research Centre, Jaipur, Rajasthan; J Sawhney, R Singh, 
Dharmavira Heart Centre, New Delhi, Delhi; K Sethi, N Bansal, Delhi Heart and Lung Institute, 
New Delhi, Delhi; A Sethia, S Sethia, Indore, Madh Prad; G Shetty, R Sudheer, St.John’s 
Medical College and Hospital, Bangalore, Karna; G Singh, R Gupta, Dayanand Medical College 
and Hospital, Ludhiana, Punjab; A Srinivas, V G, Vikram Hospital & Heart Care, Mysore, 
Karna; A T.P., L Thankaraj, Sri Gokulam Heart Centre, Trivandrum, Kerala; S Varma, A Kaur, 
Sadbhavna Medical and Heart Institute, Patiala, Punjab; M Vijan Vinod, B Thakur, Vijan 
Cardiac Center, Nashik, Mahara; I Zanwar, A Dharmarao, Hardas Heart Centre, Pune, Mahara. 
Israel-   283 patients 20 centers 
S Atar, E Lasri, Western Galilee Hospital- Nahariya, Nahariya; D Dicker, D Marcoviciu, Rabin 
Medical Center, Petach Tikva; M Elias, G Avraham Ron, HaEmek Medical Center, Afula; a 
Francis, R Ghantous, Holy Family Hospital, Nazareth; A Goldhaber, M Goldhaber, Shuali 
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Hospital, Jerusalem; E Grossman, T Dagan, Chaim Sheba Medical Center, Tel-Hashomer; Y 
Hasin, M Roshrosh, Poriya Government Hospital, Tiberias; T Hayek, A Majdoub, Rambam 
Health Care Campus, Haifa; E Klainman, I Genin, Gefen- Cardiac Center, Givatayim; M Lahav, 
T Gilat, Rabin Medical Center, Petach Tikva; B Lewis, M Ben Ari, The Lady Davis Carmel 
Medical Center, Haifa; M Lishner, M Karny, Sapir Medical Center Meir Hospital, Kfar Saba; E 
Ouzan, H Givoni, Hadassah Universtiy Hospital- Ein Kerem, Jerusalem; Y Rozenman, S 
Logvinenko, Wolfson Medical Center, Holon; E Schiff, J Sterlin, Bnai Zion Medical Center, 
Haifa; M Shochat, I Aloni, Hillel Yaffe Medical Center, Hadera; M Swissa, V Belatsky, Kaplan 
Medical Center, Rechovot; D Tsalihin, D Kisos, Ben Yair Community Clinic- Clalit Health 
Services, Beer-Sheva; D Zeltser, N Platner, Tel-Aviv Sourasky Medical Center, Tel-Aviv. 
 
Italy-   169 patients 24 centers 
A Berni, F Giovannelli, Azienda Ospedaliera Sant Andrea, Roma, RM; G Boriani, E Cervi, 
Ospedale S. Orsola- Malpighi, Bologna; G Comi, L Peruzzotti, Fondazione San Raffaele del 
Monte Tabor, Milano, MI; C Cuccia, C Forgione, Fondazione Poliambulanza Istituto 
Ospedaliero, Brescia, BS; R De Caterina, D De Pace, Azienda Ospedaliera Universitaria G. 
D'Annunzio, Chieti, CH; S De Servi, M Mariani, A.O. Ospedale Civile di Legnano, Legnano, 
MI; A Di Lenarda, C Mazzone, ASS 1 Triestina, Trieste, TS; G Di Pasquale, M Di Niro, 
Ospedale Maggiore C.A. Pizzardi, Bologna, BO; L Fattore, B Bosco, Ospedale San Giuseppe e 
Melorio, Santa Maria Capua Vetere, CE; V Grassia, E Murena, Ospedale Santa Maria Delle 
Grazie, Pozzuoli, NA; Laffi, G Gaggioli, Azienda Ospedaliera Villa Scassi, Genova, GE; G Lo 
Pinto, F Raggi, Ente Ospedaliero Ospedali Galliera, Genova, GE; P Marino, G Francalacci, A.O. 
Maggiore della Carità di Novara, Novara, NO; P Merlini, M Babbolin, Azienda Ospedaliera 
Ospedale Niguarda Cà Granda -2, Milano, MI; M Metra, M Bulgari, Spedali Civili di Brescia, 
Brescia; M Penco, E Lioy, Policlinico Casilino, Roma, RM; P Perrone Filardi, C Marciano, 
Università degli Studi di Napoli-Federico II, Napoli, NA; S Pirelli, G Paradiso, Azienda 
Ospedaliera Istituti Ospitalieri di Cremona, Cremona, CR; G Piseddu, L Fenu, Ospedale Ss. 
Annunziata Az. USL 1, Sassari, SS; A Raisaro, K Granzow, IRCCS Policlinico San Matteo, 
Pavia, PV; M Rasura, S Cannoni, Università La Sapienza-Ospedale Sant Andrea, Roma, RM; S 
Severi, M Breschi, Ospedale della Misericordia, Grosseto, GR; V Toschi, M Gagliano, A.O. 
Ospedale San Carlo Borromeo, Milano, MI; V Zacà, F Furiozzi, A.O.U. Senese Policlinico Santa 
Maria alle Scotte, Siena, SI. 
 
Japan-  1010 patients 99 centers 
T Hirahara, U Akihisa, W Masaki, Kumamoto University Hospital, Kumamoto-shi  Kumamoto; 
M Ajioka, C Matsushita, Tosei General Hospital, Seto-shi  Aichi-ken;  T Anzai, K Mino, NHO 
Hakodate National Hospital, Hakodate-shi Hokkaido;  S Arakawa, A Tsukimine, JLHWO 
Kyushu Rosai Hospital, Kitakyusyu-shi  Fukuoka;  H Endo, M Fujiwara, Clinic Horikawa, 
Kyoto-shi  Kyoto;  K Fujii, S Kozeni, Watanabe Igakukai Sakurabashi Watanabe Hospital, 
Osaka-shi  Osaka;  E Fujii, M Kotera, Mie University Hospital, Tsu-shi Mie;  S Fujimoto, K 
Omae, Nippon Steel Yawata Memorial Hospital, Kitakyushu-shi  Fukuoka;  K Fujimoto, Y 
Ichishita, NHO Kumamoto Medical Center, Kumamoto-shi Kumamoto;  T Fujita, Y Ito, 
Nagaoka Red Cross Hospital, Nagaoka-shi Niigata;  S Fukamizu, J Harada, Tokyo Metropolitan 
Hiroo Hospital, Shibuya-ku  Tokyo;  N Fukuda, C Fujimoto, NHO Zentsuji National Hospital, 
Zentsuji-shi  Kagawa;  T Funazaki, A Yamaguchi, Saiseikai Kawaguchi General Hospital, 
Kawaguchi-shi Saitama;  Y Furukawa, C Kamitake, Kobe City Medical Center General Hospital, 
Kobe-shi  Hyogo;  N Hagiwara, M Naganuma, Tokyo Women's Medical University Hospital, 
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Tokyo Metropolitan Geriatric Hospital, Itabashi-ku Tokyo;  T Haruna, Y Nakahara, 
TazukeKoufukai Igakukenkyujo Kitano Hospital, Osaka-shi  Osaka;  Y Hashimoto, Y Shimazu, 
Tesshokai Kameda Clinic, Kamogawa-shi Chiba;  Y Hiasa, Y Oga, Tokushima Red Cross 
Hospital, Komatsushima-shi  Tokushima;  T Higashikata, Y Nakagawa, Komatsu Municipal 
Hospital, Komatsu-shi Ishikawa;  A Hirayama, A Kawaguchi, Nihon University Itabashi 
Hospital, Itabashi-ku Tokyo;  Y Iesaka, C Miyamoto, Tsuchiura Kyodo General Hospital, 
Tsuchiura-shi Ibaraki;  T Iijima, K Higuchi, Fujioka General Hospital for outpatient, Fujioka-shi 
Gunma;  H Ino, H Noguchi, Kanazawa University Hospital, Kanazawa-shi Ishikawa;  T Inomata, 
K Nakamura, Kitasato University Hospital, Sagamihara-shi Kanagawa;  Y Ishibashi, T Nozaki, 
Iwate Medical University Hospital, Morioka-shi  Iwate;  Y Ishii, H Tomita, Asahikawa City 
Hospital, Asahikawa-shi Hokkaido;  S Ishimaru, M Ise, Hokkaido Social Insurance Hospital, 
Sapporo-shi Hokkaido;  K Itamoto, T Ito, Teine Keijinkai Hospital, Sapporo-shi  Hokkaido;  Y 
Ito, M Onishi, TOYOTA Memorial Hospital, Toyota-shi Aichi;  K Iwade, Y Sakuma, NHO 
Yokohama Medical Center, Yokohama-shi Kanagawa;  T Iwasaki, H Nagatome, Cardiovascular 
Hospital of Central Japan, Shibukawa-shi  Gunma;  S Kakinoki, C Adachi, Otaru Kyokai 
Hospital, Otaru-shi Hokkaido;  S Kamakura, F Nakahara, National Cerebral and Cardiovascular 
Center, Suita-shi  Osaka;  M Kamijo, S Iida, Chubu Rosai Hospital, Nagoya-shi  Nagoya;  K 
Kamiyama, R Fujii, Ijinkai Nakamura Memorial Hospital, Sapporo-shi Hokkaido;  K Kato, A 
Ishida, JLHWO Yokohama Rosai Hospital, Yokohama-shi Kanagawa;  Y Kazatani, Y Ichikawa, 
Ehime Prefectural Central Hospital, Matsuyama-shi Ehime;  H Kitazawa, C Igarashi, Tachikawa 
General Hospital, Nagaoka-shi Niigata;  Y Kobayashi, R Kikuchi, Showa University Hospital, 
Shinagawa-ku  Tokyo;  M Kohno, S Tamura, Kagawa University Hospital, Kita-gun  Kagawa; 
Y Koretsune, I Yumoto, NHO Osaka National Hospital, Osaka-shi Osaka;  M Kurabayashi, E 
Koya, Gunma University Hospital, Maebashi-shi Gunma;  T Masuyama, Y Kaneno, Hyogo 
College of Medicine Hospital, Nishinomiya-shi  Hyogo;  K Matsuda, E Ebina, MATSUDA Med 
Clinic, Sapporo-shi Hokkaido;  H Meno, M Satake, Japanese Red Cross Fukuoka Hospital, 
Fukuoka-shi  Fukuoka;  T Mita, M Takeda, Mita Medical-Cardiovascular Clinic, Sapporo-shi 
Hokkaido;  N Miyamoto, T Kimizu, Saino Clinic, Tokorozawa-shi  Saitama;  Y Miyauchi, S 
Sakamoto, Nippon Medical School Hospital, Bunkyo-ku  Tokyo;  M Munemasa, J Murata, NHO 
Okayama Medical Center, Okayama-shi Okayama;  Y Nagai, Y Sakata, Rinku General Medical 
Center, Izumisano-shi Osaka;  S Naito, H Oyama, Gunma prefectural Cardiovascular Center, 
Maebashi-shi Gunma;  Y Nishi, T Nagase, Seiwakai Nagata Hospital, Yanagawa-shi  Fukuoka; 
J Ochiai, H Junko, Nagoya Ekisaikai Hospital, Nagoya-shi  Nagoya;  T Ogawa, M Sugeno, 
Fukushima Koseikai Fukushima Dai Hospital, Fukushima-shi  Fukushima;  H Oguro, M Tanabe, 
Shimane University Hospital, Izumo-shi  Shimane;  K Okada, Y Moriyama, Ohda Municipal 
Hospital, Ohda-shi Shimane;  K Okajima, M Nakashima, Hyogo Brain and Heart Center, 
Himeji-shi Hyogo;  O Okazaki, H Wada, National Center for Global Health and Medicine 
Hospital, Shinjuku-ku  Tokyo;  K Okishige, S Kitani, Yokohama City Minato Red Cross 
Hospital, Yokohama-shi Kanagawa;  K Okumura, Y Narita, Hirosaki University School of 
Medicine & Hospital, Hirosaki-shi  Aomori;  H Onaka, H Moriyama, Takatsuki Red Cross 
Hospital, Takatsuki-shi  Osaka;  Y Ozaki, I Tanikawa, Fujita Health University Hospital, 
Toyoake-shi Aichi;  S Sakagami, A Nakano, Kanazawa Medical Center, Kanazawa-shi Ishikawa;  
S Sakuragi, N Hayashi, NHO Iwakuni Clinical Center, Iwakuni-shi  Yamaguchi;  S Sakurai, H 
Ooki, Aizawa Hospital, Matsumoto-shi  Nagano;  T Sasaki, N Oosawa, NHO Takasaki General 
Medical Center, Takasaki-City Gunma;  A Satoh, E Fujimoto, Shunkaikai Nagasaki Kita 
Hospital, Nishisonogi-gun Nagasaki;  Y Seino, M Narumi, Nippon Medical School Chiba 
Hokusoh Hospital, Inzai-shi  Chiba;  T Shirai, M Shigenari, Tokyo Metropolitan Police Hospital, 
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E Miyazaki, Toho University Ohashi Medical Center, Meguro-ku  Tokyo ;  K Sumii, H Asakura, 
MAZDA Hospital of MAZDA Co.  Lted, Aki-gun  Hiroshima;  M Takagi, S Mohri, Osaka City 
University Hospital, Osaka-shi  Osaka;  W Takahashi, K Yoshida, NHO Shinshu Ueda Medical 
Center, Ueda-shi  Nagano;  A Takahashi, N Kishi, Yokosuka Kyosai Hospital, Yokosuka-shi 
Kanagawa;  T Takahashi, Y Sakurai, Yokohama Medical Center, Yokohama-shi Kanagawa;  K 
Takeda, A yahata, Kagawa Prefectural Central Hospital, Takamatsu-shi  Kagawa;  T Takenaka, 
K Yamagishi, NHO Hokkaido Medical Center, Sapporo-shi  Hokkaido;  S Takeuchi, E 
Watanabe, Nagaoka Chuo General Hospital, Nagaoka-shi Niigata;  K Tanaka, M Uchida, Tokyo 
Metropolitan Cancer and Infectious diseases Center Kom, Bunkyo-ku Tokyo;  J Tanouchi, Y 
Nishiya, Osaka Rosai Hospital, Sakai-shi Osaka;  H Tsuboi, K Yoshida, Ogaki Municipal 
Hospital, Ogaki-shi  Gifu;  N Tsuboi, K Terakura, Social Insurance Chukyo Hospital, Nagoya-
shi Aichi;  M Uematsu, S Yasumoto, Kansai Rosai Hospital, Amagasaki-shi Hyogo;  Y Ueyama, 
M Onishi, Ueyama Clinic, Suita-shi  Osaka;  K Usuda, Y Sakai, Toyama Prefectural Central 
Hospital, Toyama-shi Toyama;  M Yagi, A Sato, Sendai Cardiovascular Center, Senndai-shi 
Miyagi;  H Yagi, T Kuroda, Koseikai Takeda Hospital, kyoto-shi Kyoto;  H Yamabe, Y 
Sakamoto, Kumamoto University Hospital, Kumamoto-shi  Kumamoto;  T Yamada, R Yamano, 
Osaka General Medical Center (Kyuseiki Sogo Iryo C), Osaka-shi  Osaka;  T Yamagishi, S 
Sasaki, Isesaki Municipal Hospital, Isesaki-shi  Gunma;  Y Yamamoto, Y Ito, Kyoto Second Red 
Cross Hospital, Kamigyo-ku Kyoto;  a Yamashina, M Takiguchi, Tokyo Medical University 
Hospital, Shinjuku-ku Tokyo;  T Yamashita, K Matsuda, The Cardiovascular Institute Hospital, 
Minato-ku  Tokyo;  T Yonehara, K Tanaka, Saiseikai Kumamoto Hospital, Kumamoto-shi 
Kumamoto;  H Yoshino, H Nomura, Kyorin University Hospital, Mitaka-shi Tokyo;  K 
Yoshioka, Y Fujiwara, Tokai University Hospital, Isehara-shi  Kanagawa. 
 
Mexico-  190 patients 13 centers 
E Bayram Llamas, A Hurtado, Fundacion Cardiovascular de Aguascalientes A.C, 
Aguascalientes, AGS; C Calvo Vargas, M Cedano Limon, Unidad de Investigacion Medica, 
Guadalajara, JAL; E Cardona Muñoz, S Hernandez, ICLE S.A., Guadalajara, JAL; J Carrillo, T 
Delgadillo, Hospital Central Dr. Ignacio Morones Prieto, San Luis Potosi, SLP; M Cásares 
Ramirez, J Franco Valles, Hospital General de Durango, Durango, DGO; N Garcia, M Alcantara 
Colin, Hospital Mocel, Mexico City, DF; A Garcia-Castillo, A Jaramillo, Cardiolink, 
Monterrey, NL; J Leiva-Pons, S de la Mora, Hospital Lomas de San Luis, San Luis Potosi, SLP; 
G Llamas Esperón, A Grajales, Hospital Cardiológica Aguascalientes, Aguascalientes, AGS; G 
Mendez-Machado, H Avila, Hospital Angeles Xalapa, Xalapa, VER; L Nevárez Ruiz, G 
Magallanes, Hospital CIMA Chihuahua, Chihuahua, CHIH; C Sánchez Díaz, A Ortiz, Unidad de 
Investigación Clínica en Medicina S.C., Monterrey, NL; R Velasco Sánchez, E Moran 
Velazquez, Hospital General Dr. Ángel Leaño, Zapopan, JAL. 
 
Netherlands-  153 patients 10 centers 
M Alhakim, I van Welsen, Flevoresearch, Almere; T Bruning, A Jones, Maasstad Ziekenhuis 
Zuider, Rotterdam; C Buiks, C Buiks, Huisartsenpraktijk Buiks, Ewijk; J de Groot, I Radder, 
Academisch Medisch Centrum, Amsterdam; R de Vos, R de Vos, Huisartsenpraktijk de Vos, 
Dordrecht; R Hazeleger, R Daniels, VieCuri Medisch Centrum Venlo, Venlo; B Kietselaer, L 
Muijs, Maastricht University Medical Center, Maastricht; H Mannaerts, E Kooiman, Ziekenhuis 
Amstelland, Amstelveen; H Mevissen, H Mevissen, Huisartsenpraktijk Westerhave, Wildervank; 
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New Zealand- 131 patients 10 centers 
R Anscombe, T O'Meeghan, M Kjentjes, Hutt Valley Health Hospital, Lower Hutt; J Benatar, H 
White, L Borthwick, Auckland City Hospital, Auckland; R Doughty, M Copley, Auckland City 
Hospital, Auckland; R Fisher, R Monkley, Waikato Hospital, Hamilton; B Green, D Scott, 
Dunedin Hospital, Dunedin; A Hamer, J Tomlinson, Nelson Hospital, Nelson; H Hart, A Turner, 
North Shore Hospital, Auckland; D Scott, R Cammell, Middlemore Hospital, Otahuhu; R 
Troughton, L Skelton, Christchurch Hospital, Christchurch; C Young, K Kennett, P3 Research 
Limited (Tauranga), Tauranga. 
 
Norway-  34 patients 4 centers 
D Atar, H Claussen, Ullevål universitetssykehus, Oslo; K Hofsøy, R Melbue, 
Hålogalandsykehuset HF, Harstad; J Sandvik, H Thunhaug, Nordland Hjertesenter AS, Bodø; A 
Tveit, S Enger, Sykehuset Asker og Bærum Bærum sykehus, Rud. 
 
Peru-   173 patients 11 centers 
G Bustamante, M Tejada Guillen, Clinica San Borja, Lima 41; J Cabrera, R Esteves Mendoza, 
Clínica Vesalio, Lima; C Chavez, C Luna, Hospital Nacional Daniel Alcides Carrion, Callao; J 
Lema, A Carrion, Hospital Nacional Arzobispo Loayza, Lima; N Llerena, S Araoz Bedregal, 
Consultorio Privado Dr. Nassil Llerena Navarro, Arequipa; F Medina Palomino, J Rodriguez, 
Clinica Medica Cayetano Heredia, Lima; J Minchola, C Bautista, Clinica San gabriel, Lima; S 
Negron Miguel, B Honores Armas, Centro Medico Naval Cirujano Mayor Santiago Tavara, San 
Borja; A Rodriguez, N Romero, Hospital Nacional Alberto Sabogal Sologuren, Callao; P Torres, 
K Fernandez Rodriguez, Consultorio Privado Dr Pedro Torres, Arequipa; P Yanac Chavez, M 
Horna, S Delgado, Hospital Alberto Sabogal Sologuren, Callao. 
 
Philippines-  125 patients 8 centers 
N Babilonia, CM Sambaz, Philippine Heart Center, Quezon;  R Barcinas, M Zapanta, Alexian 
Brothers Health and Wellness Center, Davao;  R Coching, M Vallenas, Davao Doctors Hospital, 
Davao;  G Matiga, C Enad, Perpetual Succour Hospital - Cebu, Cebu;  G Rogelio, F Joaquin, St. 
Luke's Medical Center, Quezon;  A Roxas Jr., L Gilo, The Medical City, Pasig;  R To, M 
Aquino, The Medical City, Pasig;  L Villamor, K Nario, Cebu Doctors’ University Hospital, 
Cebu. 
 
Poland-  1278 patients 49 centers 
J Adamus, J Korzeniowska-Adamus, Centrum Med. Ostrobramska NZOZ Magodent, Warszawa; 
J Baszak, J Baszak, NZOZ Przychodnia Specjalistyczna Medica, Lublin; M Bronisz, B Cieslak, 
Publiczny Specjalistyczny ZOZ w Inowroclawiu, Inowroclaw; B Busz- Papiez, A Krzystolik, 
Indywidualna Specjalistyczna Praktyka Lekarska B.Busz-Papiez, Szczecin; K Cymerman, K 
Cymerman, Indywidualna Specjalistyczna Praktyka Lekarska, Gdynia; M Dabrowska, A Ptak, 
Synexus SCM Sp z o o Oddzial w Warszawie, Warszawa; B Derlaga, E Laskowska-Derlaga, 
Spec.Gabinet Lekarski Internistyczno-Kardiologiczny, Tarnow; E Domanska, M Guziewicz, 
Centrum Medyczne CDS, Wroclaw; A Gieroba, E Zajac, SPZOZ, Lubartow; J Gniot, P 
Mroczkowski, SPZOZ w Pulawach Szpital Specjalistyczny, Pulawy; A Januszewicz, M 
Makowiecka-Ciesla, Instytut Kardiologii im. Kardynala St. Wyszynskiego, Warszawa; E 
Jazwinska- Tarnawska, P Ciezak, Synexus SCM Sp. z o.o., Wroclaw; J Jurowiecki, J Jurowiecki, 
NZOZ Przychodnia Morena, Gdansk; B Kaczmarek, A Pacholska, NZOZ Polimedica, Lodz; L 
Kaminski, L Kaminski, SP ZOZ w Przeworsku, Przeworsk; G Kania, K Tymendorf, NZOZ 
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Specjalistyczna Praktyka Lekarska, Szczecin; M Konieczny, E Benicka, KO-MED Marek 
Konieczny, Pulawy; R Korzeniak, W Borowski, NZOZ Specjalistyczna Przychodnia Lekarska 
Medikard, Plock; W Krzyzanowski, M Muzyk-Osikowicz, SPZZOZ Szpital Powiatowy im. 
M.Sklodowskiej-Curie, Ostrow Mazowiecka; W Kus, W Kus, Indywidualna Specjalistyczna
Praktyka Lekarska, Lodz; J Lesnik, T Wierzykowski, NZOZ Kutnowski Szpital Samorzadowy
Sp z oo, Kutno; J Lewczuk, M Stopyra-Poczatek, Wojewodzki Szpital Specjalistyczny we
Wroclawiu, Wroclaw; A Lubinski, K Szymanska, Uniwersytecki Szpital Kliniczny im.WAM-
Cen.Szpit.Weteran., Lodz; R Lysek, G Jaguszewska, Lecznice Citomed Sp. z o.o., Torun; L
Matyszczak-Toniak, R Sznajder, R Wnetrzak-Michalska, A Kosmaczewska, Synexus SCM Sp z
oo Oddzial w Katowicach, Katowice; S Mazur, A Chmielowski, Centrum Medyczne Medyk,
Rzeszow; P Miekus, K Kosmalska, NZOZ Pro-Cordis Sopockie Centrum Bad. Kardiolog.,
Sopot; J Mosiewicz, W Myslinski, Samodzielny Publiczny Szpital Kliniczny nr 1 w Lublinie,
Lublin; P Napora, D Biniek, NZOZ Centrum Badan Klinicznych, Wroclaw; J Nessler, B Nessler,
Specjalistyczny Gabinet Internistyczno- Kardiologiczny, Krakow; K Niezgoda, A Nej, Elblaski
Szpital Specjalistyczny z Przychodnia, Elblag; J Nowak, J Nowak, Gabinet Internistyczno-
Kardiologiczny Dr n. med. Jacek Nowak, Libiaz; M Olszewski, M Olszewski, Szpital Praski
p.w. Przemienienia Panskiego, Warszawa; D Podjacka, D Janczewska, NZOZ Kardiomed,
Elblag; H Pogorzelska, H Pogorzelska, Instytut Kardiologii im. Kardynala St. Wyszynskiego,
Warszawa; V Polaszewska-Pulkownik, E Bojanowska, Specjalistyczny Szpital Miejski im M.
Kopernika, Torun; G Raczak, A Zienciuk-Krajka, NZOZ Centrum Medyczne Kardiorytm,
Gdansk; H Rewinska, W Rozmyslowicz-Szerminska, Mazurskie Centrum Zdrowia Pro Medica,
Elk; R Ronkowski, R Ronkowski, Regionalny Szpital w Kolobrzegu, Kolobrzeg; W Ruzyllo, B
Norwa-Otto, Instytut Kardiologii im. Kardynala St. Wyszynskiego, Warszawa; D Sendrowski, D
Sendrowski, Przychodnia Specjalistyczna Falck, Gdansk; J Spyra, J Spyra, Specjalistyczna
Praktyka Lekarska Janusz Spyra, Ruda Slaska; M Szolkiewicz, A Malanska, NZOZ Eter-Med
Sp. z o.o., Gdansk; R Turbak, R Turbak, NZOZ Zdrowy Checz, Linia; W Wrobel, P
Muzalewski, Wielospec.SzpitalMiejski im.DrE.Warminskiego-SPZOZ, Bydgoszcz; A
Wysokinski, J Kudlicki, Samodzielny Publiczny Szpital Kliniczny nr 4 w Lublinie, Lublin; M
Zarebinski, R Krauze, NZOZ Starowka, Warszawa; M Zielinski, M Nawrot, Specjalistyczna
Praktyka Lekarska, Chojnice.
Portugal-  180 patients 10 centers 
F Matias, Cruz Vermelha Portuguesa- Sociedade de Gestão Hospitalar SA, Lisboa; J Correia, J 
Correia, Hospital de Santo Andre EPE, Leiria; V Gil, S Lopes, Hospital Fernando da Fonseca 
(Amadora Sintra), Amadora; J Madeira, D Maymone, Hospital de São Bernardo, Setúbal; D 
Martins, E Neves, Hospital do Divíno Espírito Santo, Ponta Delgada; P Monteiro, D Oliveira, 
Hospitais da Universidade de Coimbra, Coimbra; P Monteiro, A Leitao Marques, C Castro, 
Centro Hospitalar de Coimbra, Coimbra; A Salgado, A Gonçalves, H. Sao Marcos, Braga; O 
Santos, L Veiga Pais Nunes, H Sao Teotonio, Viseu; J Santos, D Soares, Hospital Infante D. 
Pedro S.A., Aveiro. 
Romania-  410 patients 23 centers 
P Albulescu, M Ciortea, Spitalul Clinic Judetean de Urgenta Ilfov, Bucuresti; E Apetrei, C 
Matei, Institutul de Boli Cardiovasculare Prof. Dr. C.C. Iliescu, Bucuresti; D Bartos, E Badila, 
Spitalul Clinic de Urgenta Floreasca Bucuresti, Bucuresti; C Bengus, V Ochean, Spitalul 
Judetean de Urgenta Sf. Pantelimon Focsani, Focsani; E Bobescu, B Doka, Spitalul Clinic 
Judetean de Urgenta Brasov, Brasov; F Bolohan, F Bolohan, Centrul Clinic de Urgenta de Boli 
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Medicali's, Timisoara; I Coman, M Ghionea, Inst. Urgenta Boli Cardiovasculare Prof.Dr.C.C. 
Iliescu, Bucuresti; M Constantinescu, M Constantinescu, S.C. Medcon S.R.L., Buzau; M 
Creteanu, M Parasteac, Spitalul Judetean de Urgenta Sf. Ioan cel Nou Suceava, Suceava; M 
Cristea, M Anciu, Centrul Medical de Diagnostic si Tratament, Bucuresti; D Crisu, D Jemna, 
Consultmed SRL, Iasi; I Dobre, O Voicu, Spitalul Judetean de Urgenta Targoviste, Targoviste; D 
Dobreanu, I Sirbu, Spitalul Clinic Judetean de Urgenta Tg. Mures, Targu Mures; D Dragomir, S 
Jurca, CMDTA Dr. Nicolae Kretulescu, Bucuresti; L Iosipescu, L Costache, Spitalul Clinic 
Judetean de Urgenta Bacau, Bacau; B Minescu, D Serban, Spitalul Judetean de Urgenta Braila, 
Braila; C Pop, M Cozma, Cabinet Medical Individual de Cardiologie Dr. Calin Pop, Baia Mare; 
M Popescu, A Ardelean, Spitalul Clinic Judetean de Urgenta Oradea, Oradea; D Sipciu, P 
Plosca, S.C. Duo Medical S.R.L., Bucuresti; S Stamate, C Spinu, Spitalul Clinic de Urgenta Sf. 
Pantelimon, Bucuresti; L Topolnitchi, O Topolnitchi, Spitalul Judetean Sf. Gheorghe, Sfantu 
Gheorghe; M Tudoran, C Tudoran, Spitalul Clinic Judetean de Urgenta Timisoara, Timisoara. 
Russian Federation- 1151 patients 66 centers 
M Ruda, N Zhukova, FSBI Russian Cardiology Research and Production Complex, Moscow; 
G Arutyunov, T Chernyavskaya, Russian State Medical University, Moscow; M Ballyuzek, 
L Alexandrova, St-Petersburg Clinical Hospital of Russian Academy of Science, Saint-
Petersburg; O Barbarash, A Bashkireva, MIH Kemerovo Cardiology Dispensary, Kemerovo; 
B Bart, V Larina, SBEU Russia National RMU n.a. N.I. Pirogov of MoH of RF, Moscow; 
D Belenky, Y Kosolapov, SBIH of Novosibirsk Region Clinical Emergency Hospital 2, 
Novosibirsk; S Berns, E Yukhno, SI SRI of Complex Problems of Cardio-Vascular Diseases of 
SB, Kemerovo; I Bokarev, T Khlevchuk, Moscow City Clinical Hospital 20, Moscow; 
G Chumakova, O Pokutneva, TSIH Altay Territorial Cardiology Dispensary, Barnaul; A Demko, 
A Masin, Dep. Clin. Hosp. on Station Kemerovo of OAO Russian Railway, Kemerovo; 
P Dovgalevsky, N Puchinyan, Saratov Institute of Cardiology, Saratov; O Drapkina, 
E Zyatenkova, First Moscow State Medical University n.a. I.M. Sechenov, Moscow; L Egorova, 
L Egorova, StP SHI Clinical hospital of St. Luka, Saint-Petersburg; V Esip, N Kirichek, St. 
Petersburg State Healthcare Institution Diagnostic Cent, St. Petersburg; A Filatov, I Soin, State 
healthcare facility Tula Regional Hospital, Tula; O Gilinskaya, E Valuyshkih, SI SRI of 
Physiology SB RAMS, Novosibirsk; M Glezer, S Valovyeva, SBHI City Clinical Hospital 59 of 
HD of city of Moscow, Moscow; S Golitsyn, T Kratskina, FSBI Russian Cardiology Research 
and Production Complex, Moscow; B Goloshchekin, I Laptev, St-Petersburg SIH City Hospital 
15, St-Petersburg; N Gratsiansky, O Mazovets, SIH of Moscow City Clinical Hospital 29 n.a. 
Baymana, Moscow; Y Karpov, V Buza, FSBI Russian Cardiology Research and Production 
Complex, Moscow; Y Karpov, B Kosenko, Emergency Medical Care Hospital 1, Voronezh; 
V Khirmanov, I Kireenkov, All-Russian Center of Emergency and Radiation Medicine MCRS, 
St-Petersburg; A Khokhlov, O Sinitsina, Municipal MI Clinical Hospital 2, Yaroslavl; 
R Khokhlov, E Tsareva, Voronezh regional clinical hospital 1 Interregional cardio, Voronezh; 
O Khrustalev, A Khrustalev, Yaroslavl Regional SBHI Regional Clinical Hospital, Yaroslavl; 
V Kostenko, S Karabalieva, St. Petersburg SHI City Polyclinic 109, St. Petersburg; N Koziolova, 
E Polyanskaya, SHI Perm Regional Hospital of War Veteran’s, Perm; O Kozyrev, O Kostenko, 
Smolensk State Medical Academy of Roszdrav, Smolensk; V Kuznetsov, A Rychkov, SRI of 
Cardiology of SB of RAMS br Tumen cardiology Center, Tumen; O Lavrova, L Tereschenko, 
Pavlov State Medical University of St.Petersburg, St. Petersburg; S Levashov, E Volkova, SBHI 
Regional Clinical Hospital 3, Chelyabinsk; R Libis, A Maslova, Orenburg State Medical 
Academy of RosZdrav, Orenburg; I Libov, Y Moiseeva, City Clinical Hospital named after 
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Petersburg; Y Lukyanov, D Lamden, SEIHPE SPb SMU n.a. Pavlov affiliate 1 of FAHSD, St. 
Petersburg; K Nikolaev, A Nikolaev, SBIH of Novosibirsk Region City Clinical Hospital 19, 
Novosibirsk; I Nikolskaya, O Khromova, MBHI of Novosibirsk City Clinical Hospital 25, 
Novosibirsk; N Novikova, S Patrusheva, Central Clininical Hospital of Siberian branch of 
RAOS, Novosibirsk; E Panchenko, P Laguta, FSBI Russian Cardiology Research and Production 
Complex, Moscow; A Panov, R Nilk, FSI FC of Heart Blood and Endocrinology n.a. Almazov, 
St. Petersburg; E Polkanova, I Matveeva, SHI Center of Occupational Pathology, St-Petersburg; 
N Poluyanova, N Pikalova, FSI Outpatient Clinic 3 President of RF, Moscow; T Raskina, 
M Letaeva, SBHI of Kem. Regional Clinical Hospital for War Veterans, Kemerovo; A Rebrov, 
N Karoli, SEIHPE Saratov State Medical University, Saratov; M Repin, N Rodina, LLC Institute 
of Medical Investigations, St. Petersburg; I Shaposhnik, E Lebedev, City Hospital 1, 
Chelyabinsk; Z Shogenov, M Agirov, CityClinicalHospital81, Moscow; B Sidorenko, 
S Vorontsova, FSD ESMC of GMD of the president of RF Central Clinical Hospital, Moscow; 
I Sinitsina, V Orlov, M Golshmid, RMA of Post Graduate Education of MoH and SD of RF, 
Moscow; Z Sizova, N Lapidus, State Healthcare Institution of city of Moscow Cardiologic, 
Moscow; K Sobolev, S Erofeeva, City Clinical Hospital No.61, Moscow; E Suprun, D Dronov, 
Municipal Healthcare Institution Medicosanitary Unit 9, Omsk; N Tarasov, L Isakov, FGHI 
MSU of the MoIA of the RF for the Kemerovo Region, Kemerovo; S Tereshenko, I Kositsyna, 
Moscow State Medico-stomat. University City Hospital 68, Moscow; E Tikhonova, A Solovyev, 
JSC Med. Scient. Production Association Clinic Dvizhenie, Volgograd; A Timofeev, S Bulygin, 
MIH City Hospital 1, Barnaul; S Ustyugov, M Rossovskaya, MBHI City Clinical Emergency 
Hospital n/a N.S. Karpovich, Krasnoyarsk; A Vishnevsky, A Kirgizova, SPb SIH Pokrovskaya 
City Hospital, St-Petersburg; D Volkov, N Rodina, Medical Institute on Krestovsky, St. 
Petersburg; V Yakusevich, A Petrochenko, SHI Clinical Hospital for Emergency Medical Care 
n.a N.V. Solovyev, Yaroslavl; S Yakushin, N Nikulina, Ryazan Regional Clinincal Cardiology
Dispensary, Ryazan; D Zateyshchikov, I Zotova, SBHI of city of Moscow City Hospital 17,
Moscow; A Zateyshchikova, B Mankhaeva, SBHI City Clinical Hospital 51 of Hd of Moscow
city, Moscow; S Zenin, O Kononenko, SBIH Novosibirsk Regional clinical cardiology
Dispensary, Novosibirsk; G Zubeeva, I Motylev, Municipal Medicoprophylactic Institution City
Hospital 33, Nizhny Novgorod.
Serbia-  277 patients 14 centers 
S Apostolovic, D Djordjevic-Radojkovic, Clinical Center of Nis, Nis; V Celic, A Majstorovic, 
Clinical Center Dragisa Misovic, Belgrade; N Cemerlic Adjic, M Bjelobrk, Institute of 
Cardiovascular Diseases Sremska Kamenica, Sremska Kamenica; N Despotovic, P Erceg, 
Clinical Center Zvezdara, Belgrade; S Ilic, B Ilic, Institute for Treatment and Rehabilitation 
Niska Banja, Niska Banja; M Krotin, A Djokovic, Clinical Center Bezanijska Kosa, Zemun; V 
Miloradovic, I Djokic, Clinical Center Kragujevac, Kragujevac; P Otasevic, N Tasic, Dedinje 
Cardiovascular Institute, Belgrade; T Potpara, M Polovina, Clinical Center of Serbia, Belgrade; 
B Putnikovic, T Kalezic, Clinical Center Zemun, Zemun; P Seferovic, I Milinkovic, Institute of 
CV Disease Clinical Center of Serbia, Belgrade; D Tavciovski, Z Davicevic, Military Medical 
Academy, Belgrade; Z Vasiljevic-Pokrajcic, P Mitrovic, Clinical Center of Serbia, Belgrade; B 
Vujisic Tesic, M Ostojic, M Tesic, Institute of CV Diseases Clinical Center of Serbia, Belgrade. 
Slovakia-  405 patients 15 centers 
V Ambrovicova, I Ambrovic, CELL B s.r.o., Levice; A Banikova, A Banikova, Kardiomed 
s.r.o., Lucenec; A Dukat, V Kosmalova, Univerzitna nemocnica Bratislava Nemocnica Stare
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Vankova, FNsP Nove Zamky, Nove Zamky; A Dzupina, M Dzupinova, Alian s.r.o., Bardejov; K 
Hatalova, R Hatala, Cardioconsult s.r.o., Bratislava; M Hranai, J Hofmanova, Kardiocentrum 
Nitra s.r.o., Nitra; V Kasperova, A Reptova, Univerzitna nemocnica Bratislava Nemocnica Stare 
Mesto, Bratislava; J Mazur, J Mazur, Kardioonkologia s.r.o., Dolny Kubin; D Pella, J Fedacko, 
Cardio D&R s.r.o., Kosice; L Ruffini, J Morsky, Nestatna kardiologicka ambulancia, Rimavska 
Sobota; M Slanina, J Kmec, FNsP J. A. Reimana, Presov; A Zachar, M Kokles, Univerzitna 
nemocnica Bratislava Nemocnica ak. L. Derera, Bratislava; P Zareczky, D Bollova, Cardio s.r.o., 
Galanta. 
South Africa-  277 patients 15 centers 
J Badenhorst, L Erasmus, Unitas Hospital, Lyttelton, Gauteng; M Basson, M Poynton, Tiervlei 
Trial Centre, Belville, W Cape; A Dalby, J Allman, Millpark Hospital, Parktown West, Gauteng; 
G Ellis, L Botha, Helderberg Clinical Trials, Somerset West Western Cape, W Cape; J 
Engelbrecht, M Mostert, Somerset West, W Cape; M Essop, T Nunkoo, Chris Hani Baragwanath 
Hospital, Diepkloof, Gauteng; M Gani, L Wilson, GCT- Mercantile CTC, Port ELizabeth, E 
Cape; Y Kelfkens, Y Kelfkens, Potchefstroom, NW; I Mitha, J Taljaard, Worthwhile Clinical 
Trials, Benoni, Gauteng; D Naidoo, Y Duki, Research Clinic, Durban, KZ-Natal; F Snyders, M 
Munnik, Wilgers Medical Consortium, Pretoria, Gauteng; P Soma, H Johnston, University of 
Pretoria Clinical Trial Unit, Pretoria, Gauteng; N van der Merwe, Y Goosen, Medi-Clinic 
Bloemfontein, Bloemfontein, Free State; L van Zyl, M le Roux, Clinical Project Research, 
Worcester; T Venter, L Wessels, Union Hospital, Alberton, Gauteng. 
South Korea-  230 patients 23 centers 
HJ Bae, MG Han, Seoul National University Bundang Hospital, Gyeonggi-do;  JK Cha, DH 
Kim, Dong-A University Medical Center, Busan;  BR Cho, DR Ryu, Kangwon National 
University Hospital, Gangwon-do;  HH Choi, KS Hong, Chuncheon Sacred Heart Hospital, 
Gangwon-do;  WS Chung, YS Oh, The Catholic University of Korea Seoul St. Mary Hospital, 
Seoul;  SH Han, KH Lee, Gachon University Gil Hospital, Incheon;  TJ Hong, HW Lee, Pusan 
National University Hospital, Pusan;  MS Hyon, JW Jung, Soonchunhyang University Hospital, 
Seoul;  HK Jeon, JM Lee, The Catholic University of Korea Uijeongbu St.Mary's Hospital, 
Gyeonggi-do;  DH Kang, KJ Choi, Asan Medical Center, Seoul;  CJ Kim, ES Jin, Kyung Hee 
University Hospital at Gandong, Seoul;  DS Kim, JS Seo, Inje University Busan Paik Hospital, 
Busan;  HS Kim, MJ Cha, Seoul National University Hospital, Seoul;  JT Kim, MS Park, 
Chonnam National University Hospital, Gwangju;  JH Kim, JH Park, Chungnam National 
University Hospital, Daejeon;  JS Kim, SJ Park, Samsung Medical Center, Seoul;  SH Kim, JB 
Seo, Seoul Metropolitan Government Seoul National University, Seoul;  YJ Kim, MY Chun, 
Ewha Womans University Mokdong Hospital, Seoul;  MH Lee, BY Joung, Severance Hospital 
Yonsei University College of Medicine, Seoul;  SH Lee, DG Shin, Yeungnam University 
Hospital, Daegu;  J Namgung, JJ Kwak, Inje University Ilsan Paik Hospital, Gyeonggi-do;  SW 
Rha, JO Na, Korea University Guro Hospital, Seoul;  SJ Rim, JY Kim, Gangnam Severance 
Hospital, Seoul. 
Spain-   166 patients 14 centers 
M Arcocha Torres, A Manzanal Rey, Hospital de Basurto, Bilbao, 48; J Blanco Coronado, I 
Puertas, Hospital Virgen del Mar, Almeria, 4; J Bruguera Cortada, P Cabero, H del Mar, 
Barcelona, 8; C Calvo, G Calvo, HCU de Santiago, La Coruna, 15; A de Arce Borda, A Asensio, 
Hospital de Donostia, San Sebastian, 20; E Diez Tejedor, M Pérez Guevara, HGU La Paz, 
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Hernandez Madrid, A Delgado, HU Ramon y Cajal, Madrid, 28; V Lopez Garcia-Aranda, R 
Barquero, HU Virgen Macarena, Sevilla, 41; L Manzano, S Blanco Abril, Hospital Universitario 
Ramón y Cajal, Madrid, 28; J Merino, M Diaz-Pintado, H.G.U.La Paz, Madrid, 28; J Arias, M 
Fernandez, R Fernandez Alvarez, Policlinico de Vigo-Povisa, Vigo, 36; M Terns, M Dachs 
Delgado, CAP El Remei, Barcelona, 8; R Villuendas, L Astier, Hospital Universitari Germans 
Trias i Pujol, Barcelona, 8. 
 
Sweden-  252 patients 16 centers 
P Appelros, A Åkerberg, Universitetssjukhuset Örebro, Örebro; K Berndtsson Blom, R 
Andersson, Ladulaas kliniska studier, Skene; P Blomström, L Persson, Akademiska Sjukhuset, 
Uppsala; T Carlsson, A Stener Bengtsson, Hjärthuset AB, Varberg; S Dettmann, S Östberg, 
Mora lasarett, Mora; J Engdahl, L Karlsson, Länssjukhuset Halmstad, Halmstad; J Herlitz, L 
Winberg, Sahlgrenska Sjukhuset, Göteborg; S Juul-Möller, H Jernhed, Universitetssjukhuset 
MAS, Malmö; P Koskinen, E Håkansson, PharmaSite AB, Malmö; P Kozak, M Edlund, 
ProbarE, Lund; L Malmqvist, G Eriksson, Köpings lasarett, Köping; F Randers, J Moodh, 
Sahlgrenska Universitetssjukhuset Mölndal, Mölndal; A Rautio, M Johansson, Sensia Forskning, 
Luleå; F Rönn, C Sundholm, Norrlands Universitetssjukhus, Umeå; A Stenberg, A Gunnarsson, 
Lindesbergs lasarett, Lindesberg; J Thulin, M Broberg, Capio Citykliniken Lund, Lund. 
 
Switzerland-  5 patients 1 center 
T Moccetti, I Petrova Slater, Cardio Centro Ticino, Lugano. 
 
Taiwan-  234 patients 15 centers 
CC Cheng, WS Wu, Chi-Mei Medical Center - Yongkang, Tainan;  CE Chiang, WC Yu, Taipei 
Veterans General Hospital, Taipei;  FT Chiang, YW Wu, National Taiwan University Hospital, 
Taipei;  CW Chiou, TC Yeh, Kaohsiung Veterans General Hospital, Kaohsiung;  CH Hsia, YP 
Chen, Changhua Christian Hospital, Changhua;  JL Huang, YF Chen, Taichung Veterans 
General Hospital, Taichung;  CT Kuo, CL Wang, Chang Gung Memorial Hospital - Linkou, 
Taoyuan;  WT Lai, TH Lin, Kaohsiung Medical University Chung-Ho Memorial Hospital, 
Kaohsiung;  JT Lee, CC Cheng, Tri-Service General Hospital, Taipei;  PY Pai,  KH Lin, China 
Medical University Hospital, Taichung;  KG Shyu, CZ Chiu, Shin Kong Wu Ho-Su Memorial 
Hospital, Taipei;  WK Tseng, YF Pan, E-Da Hospital, Kaohsiung;  KC Ueng, SC Lee, Chung-
Shan Medical University Hospital, Taichung;  JH Wang, WC Tsai, Hualien Tzu Chi Hospital, 
Hualien;  HI Yeh, JY Kuo, Mackay Memorial Hospital  - Tamsui, New Taipei. 
 
Thailand-  115 patients 8 centers 
K Jirasirirojanakorn, K Pornchaiyasit, Bhumibol Adulyadej Hospital, Bangkok;   
P Kaewsuwanna, W Sinthusopa, Maharat Nakhon Ratchasima Hospital, Nakhon Ratchasima;   
S Kiatchoosakun, S Sriprasert, Srinagarind Hospital, Khon Kaen;  P Laothavorn,  
P Bamrungpong, Phramongkutklao Hospital, Bangkok;  D Piyayotai, A Sripracha, Thammasat 
Chalerm-Prakiat Hospital, Pathumthani;  P Sritara, P Panpunuan, Ramathibodi Hospital, 
Bangkok;  A Sukonthasarn, W Mekara, Maharaj Nakorn Chiang Mai Hospital, Chiang Mai;   
Y Vorasettakarnkij, E Puripun, King Chulalongkorn Memorial Hospital, Bangkok. 
 
Turkey-  111 patients 17 centers 
M Acikel, M Acikel, Ataturk University Medical Faculty, Erzurum; H Akilli, H Demir, Konya 
Necmettin Erbakan University Meram Faculty of Medicine, Konya; N Ata, N Ata, Osmangazi 
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Research Hospital, Izmir; N Cakmak, A Calik, Siyami Ersek Hospital, Istanbul; M Cayli, M 
Cayli, Adana Numune Training and Research Hospital, Adana; C Ceyhan, C Ceyhan, Adnan 
Menderes University Medical Faculty, Aydin; D Erdogan, D Erdogan, Suleyman Demirel 
University Medical Faculty., Isparta; C Ermis, C Ermis, Akdeniz Univesity Medical Faculty, 
Antalya; K Kabul, H Demir, GATA (Gulhane Military Medical School), Ankara; M Kanadasi, 
M Kanadasi, Cukurova University Medical Faculty, Adana; A Oto, A Oto, Hacettepe University 
School of Medicine, Ankara; O Turgut, I Tandogan, Cumhuriyet University Medical Faculty, 
Sivas; R Yalcin, R Yalcin, Gazi University, Ankara; F Yigit, F Yigit, Baskent University 
Medical Faculty, Adana; Z Yigit, Z Yigit, Istanbul University Cardiology Institute, Istanbul; M 
Zoghi, M Zoghi, Ege University Medical Faculty Hospital, Izmir. 
Ukraine-  1148 patients 46 centers 
V Batushkin, M Azhdari, Kyiv City Clinical Hospital 5, Kyiv; A Bazylevych, Z Vlasyuk, City 
Communal Clinical Hospital #5, Outpatient Department, Danylo Galytskiy Lviv National 
Medical University, Lviv; I Bereznyakov, M Lebedynskaya, City Clinical Multifield Hospital 
#25, Cardiology Department; Kharkiv Medical Academy of Postgraduate Education, Kharkiv; S 
Dotsenko, R Kulynych, Communal Institution Zaporizhzhya Regional Clinical Hospital, 
Zaporizhzhya State Medical University, Chair of Internal Diseases #3, Zaporizhzhya; G Dzyak, 
L Vasilyeva, Сommunal Institution Dnipropetrovsk Regional Clinical Centre of Cardiology and 
Cardiosurgery of Dnipropetrovsk Regional Council, Department of Electrophysiological 
Research and Anaesthesiological Care,  State Institution Dnipropetrovsk Medical Academy of 
the Ministry of Health of Ukraine, Dnipropetrovsk; A Faynyk, M Sorokivskyy, Lviv Regional 
State Clinical Medical and Diagnostic Cardiology Centre, Lviv; V Gavrysyuk, Y Dzublik, SI 
National Institute of Phthisiology and Pulmonology named after F.G.Yanovsky AMS of Ukraine, 
Kyiv; L Horbach, V Husyev, Communal City Clinical Hospital 8, Lviv; O Godlevska, Y 
Samburg, City Clinical Emergency Hospital named after O.I. Meshchaninov, Department of 
Therapy #1, Kharkiv Medical Academy of Postgraduate Education, Kharkiv; O Karpenko, I 
Nevolina, Kiyv Municipal Clinical Hospital 1, Kyiv; Y Karpenko, O Blihar, Odesa Regional 
Clinical Hospital, Department of Cardiology, Odesa State Medical, Odesa; I Kaydashev, N 
Gerasimenko, City Clinical Hospital #1, Therapeutic Department; Ukrainian Medical 
Stomatological Poltava; S Kolomyyits, V Vasylets, Odesa Municipal Clinical Hospital 9, Odesa; 
M Kopytsya, O Petyunina, State Institution Institute of Therapy named after L.T. Malaya of 
Academy of Medical Sciences of Ukraine, Kharkiv; V Kotseruba, M Dvoieglazova, Chernigiv 
City Hospital 1, Chernigiv; V Koval, O Ohirko, Communal City Clinical Hospital 8, Lviv; O 
Koval', P Kaplan, Communal Institution Dnipropetrovsk Clinical Association of Emergency 
Medical Care of Dnipropetrovsk Regional Council, Department  of Cardiology for Treatment of 
Patients with Myocardial Infarction #2, State Institution Dnipropetrovsk Medical Academy of 
the Ministry of Health of Ukraine, Dnipropetrovsk; I Kraiz, N Usan, Kharkiv Central Clinical 
Hospital Ukrzaliznitsi, Kharkiv; O Kraydashenko, R Stets, Zaporizhzhya State Medical 
University, Communal Institution City Clinical Hospital #6, chair of clinical pharmacology and 
pharmacotherapy, Zaporizhzhia; I Kupnovytska, I Kupnovytska, Iv-Frank. Ivano-Frankivsk 
Regional Clinical Cardiological Center, Department of Arterial Hypertension, Ivano-Frankivsk 
State Medical  University, Ivano-Frankivsk; Y Kyyak, Y Kyyak, Communal City Clinical 
Emergency Hospital, Cardiology Department, Danilo Galytskiy Lviv State Medical University, 
Lviv; V Lizogub, O Gorna, Kyiv City Clinical Hospital #12, Department of Cardiology,  O.O. 
Bogomolets National Medical University, Kyiv; Y Malynovsky, S Fedotov, MI RMC of 
Cardiovascular Diseases of Zaporizhzhia RC, Zaporizhzhia; L Ostrovska, L Ushakova-Sokolova, 




 http://ahajournals.org by on December 17, 2019
22
Center The M.D. Strazhesko Institute of Cardiology of the Academy of Medical Sciences of 
Ukraine, Kyiv; P Potapenko, A Nekrasa, Luhansk Municipal Clinical Hospital 1, Luhansk; O 
Prokhorov, V Leonidova, Kharkiv City Clinical Hospital 27, Kharkiv; B Rebrov, O Gamachek, 
Lugansk Regional Clinical Hospital, Lugansk; M Rishko, T Chendey, Transcarpathian Regional 
Cardiology Dispensary, Department of Cardiology, Uzhgorod National University, Uzhgorod; I 
Rudyk, I Rudyk, SI Institute of Therapy named after L.T.Mala NAMS of Ukraine, Kharkiv; V 
Shatilo, V Ishchuk, Institute of Herontology AMS of Ukraine, Kyiv; V Shcherbak, I 
Goncharova, Vinnytsya city clinical hospital 1, Vinnitsya; N Shvetz, M Zamlynskyy, City 
Clinical Hospital 1, Mykolayiv; Y Sirenko, Y Sirenko, State Institution National Scientific 
Center The M.D. Strazhesko Institute of Cardiology of National Academy of Medical Science of 
Ukraine, Kyiv; M Stanislavchuk, L Perebetiuk, Vinnytsya Regional Clinical Hospital named 
after M.I. Pyrogov, Department of Cardiology, Vinnytsya National Medical University named 
after M.I. Pyrogov, Vinnytsya; O Sychov, S Lyzohub, NSC Cardiology Institute named after 
M.D. Strazheska, Kyiv; V Tseluyko, I Kuznetsov, Communal Healthcare Institution Kharkiv
City Clinical Hospital #8, Cardiology Department,  Kharkiv Medical Academy of Postgraduate
Education, Kharkiv; S Tykhonova, S Tykhonova, Centre of Reconstructive and Rehabilitation
Medicine (University Clinic) of Odesa State Medical University of Ukraine, Therapeutic
Department, Odesa State Medical University MoH of Ukraine, Internal Medicine Department #2,
Odessa; I Vakaliuk, I Drapchak, Ivano-Frankivsk Regional Clinical Cardiological Center,
Infarction Department #2,  Ivano-Frankivsk State Medical  University, Ivano-Frankivsk; M
Vatutin, O Sklyanna, V.K.Gusak Institute of Urgent and Recovery Surgery AMSU, Department
of Urgent Cardiology and Rehabilitation, M.Gorky Donetsk National Medical University,
Donetsk; V Vizir, O Goncharov, Communal Institution City Hospital #7, Department of
Cardiology, Zaporizhzhya State Medical University, Zaporizhzhia; V Volkov, S Serik, Institute
of Therapy named after L.T. Malaya NAMS Ukraine, Kharkiv; A Yagensky, V Nahrebetskyy,
Lutsk City Clinical Hospital, Volyn Regional Center of Cardiovascular Disease and
Thrombolysis, Lutsk; L Yena, I Mudruk, Institute of Herontology AMS of Ukraine, Kyiv; O
Zharinov, Y Logvinov, National Medical Academy of Postgraduate Education named after
P.L.Shupyk, Department of Cardiology and Functional Diagnostics, Kyiv; S Zhurba, T Shandra,
Cherkaskiy Region Cardiological Center, Cherkasy.
United Kingdom-  400 patients 31 centers 
R Aggarwal, S Smith, Basildon University Hospital, Basildon, Essex; I Beeton, S Dunn, St 
Peter's Hospital, Chertsey, Surrey; M Blagden, R Price, Avondale Surgery, Chesterfield, Derby; 
J Camm, K Dougal, St Georges Hospital, London, GT LON;O Chapman, D Davies, University 
Hospital of Coventry and Warwickshire, Coventry, Warwks; A Choy, J Duff, Ninewells 
Hospital, Dundee; A Cohen, R Wilmott, King's College Hospital, London, GT LON; D D'Costa, 
M Green, New Cross Hospital, Wolverhampton, WSTMID; H Douglas, D Dickinson, University 
Hospital Aintree, Liverpool, MERSYD; F Lie, V Ramasamy, Whipps Cross Hospital, London, 
GT LON; S Lindsay, C Atkinson, Bradford Royal Infirmary, Bradford, WYORKS; N Linker, M 
Finlayson, James Cook Hospital, Middlesborough, T&W; G Lip, R Brown, City Hospital, 
Birmingham; P MacCallum, P Ebano, Barts and the London NHS Trust, London; P MacCallum, 
P Ebano, Wolfson Insitute of Preventive Medicine, London, GT LON; M MacLeod, C McGhee, 
Forth Valley Royal Hospital, Larbert, AYR; P Marazzi, D Jones, East Horsley Medical Centre, 
East Horsley, Surrey; T Maxwell, C Isted, Little Common Surgery, Bexhill on Sea, E.SUSX; R 
More, L Helliwell, Lancashire Cardiac Centre, Blackpool, LANCS; A Moriarty, A Mackin, 
Craigavon Area Hospital, Belfast, BFS; D Murdoch, A Andrews, Southern General Hospital 
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LOTH; M Pye, L Wright, York Hospital, York, E YORK; J Roberts, D Avery, Mayfield Medical 
Centre, Paignton, DEVON; R Senior, G Young, Northwick Park Hospital, Middlesex, MDDSX; 
M Sopher, S Kennard, Royal Bournemouth Hospital, Bournemouth, Dorset; R Storey, C Bridge, 
University of Sheffield SOM & Biomed Sciences, Sheffield, SYORKS; W Turner, M Walker, 
The Burbage Surgery, Leicester, LEICS; A Venkataraman, M Gilchrist, George Eliot Hospital, 
Nuneaton, Warwks; R Watkin, A Chung, Good Hope District General Hospital, Birmingham, 
WSTMID; A Wright, J Wright, Hathaway Medical Centre, Swindon, WILTS. 
United States- 3907 patients 336 centers 
P Abi-Mansour, M Panella, Advocate Health and Hospitals Corporation, Oak Lawn, IL; K 
Adams, J Lohman, Jacksonville Heart Center, Jacksonville, FL; J Adler, B Barash, Clinicos 
Clinical Research, Colorado Springs, CO; P Adler, S Reiling, Yardley, PA; R Aggarwal, P Beck, 
CVMS Research Institute LLC, Jupiter, FL; A Ahmad, A Hussain, East Texas Cardiology PA, 
Houston, TX; H Ahmadpour, G Lim, Advanced Medical Research, Lakewood, CA; F Akhter, S 
Brubaker, Cardiologists of Clark & Champaign Counties Inc, Springfield, OH; J Alexander, E 
Genova-Peeva, North Shore University Health System, Bannockburn, IL; P Aliyar, W Godsey, 
Midwest Internal Medicine, Lake Havasu City, AZ; J Allison, R Biscardi, Three Rivers Medical 
Associates PA, Columbia, SC; A Almquist, H MacDonald, Minneapolis Heart Institute, 
Minneapolis, MN; T Alsheikh, B Lane, Langhorne Cardiology Consultants Incorporated, 
Pensacola, FL; K Amin, S Khetarpal, Conyers, GA; M Amin, F Persechino, Research Alliance 
Incorporated, Clearwater, FL; J Anderson, T York, Integris Cardiovascular Physicians LLC, 
Oklahoma City, OK; T Arnold, R Shoaf, Triangle Medical Research, Lexington, NC; A Arouni, 
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